EP1601948A2 - Systeme zur differential-ionenmobilitätsanalyse - Google Patents

Systeme zur differential-ionenmobilitätsanalyse

Info

Publication number
EP1601948A2
EP1601948A2 EP04719211A EP04719211A EP1601948A2 EP 1601948 A2 EP1601948 A2 EP 1601948A2 EP 04719211 A EP04719211 A EP 04719211A EP 04719211 A EP04719211 A EP 04719211A EP 1601948 A2 EP1601948 A2 EP 1601948A2
Authority
EP
European Patent Office
Prior art keywords
sample
dms
mobility
ion
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04719211A
Other languages
English (en)
French (fr)
Inventor
Raanan A. Miller
Angela Zapata
Erkinjon G. Nazarov
Cristina E. Davis
Gary A. Eiceman
Anthony B. Bashall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charles Stark Draper Laboratory Inc
Sionex Corp
Original Assignee
Charles Stark Draper Laboratory Inc
Sionex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/462,206 external-priority patent/US7005632B2/en
Application filed by Charles Stark Draper Laboratory Inc, Sionex Corp filed Critical Charles Stark Draper Laboratory Inc
Publication of EP1601948A2 publication Critical patent/EP1601948A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G01N27/622—Ion mobility spectrometry
    • G01N27/624—Differential mobility spectrometry [DMS]; Field asymmetric-waveform ion mobility spectrometry [FAIMS]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath

Definitions

  • This application claims the benefit of Provisional Application No. 60/549,004, filed March 1, 2004, entitled "Chemical Agent Detector” by Raanan A. Miller et al, (Docket No. M143; US Express Mail Label No. EO 902 877 387US.
  • This application is a continuation-in-part of US Application 10/321,822, filed December 16, 2002, which is a continuation of US Application No. 09/358,312, filed July 21, 1999 (Patent No. 6,495,823).
  • BACKGROUND OF THE INVENTION Spectrometers are used in chemical analysis for identification of compounds in a sample. In some cases a quick indication of presence of particular compounds in a sample is needed, while at other times the goal is complete identification of all compounds in a chemical mixture. Accordingly, samples may be taken directly from the environment and analyzed or may be prepared by processing and/or separating the constituents before spectrometric analysis.
  • Spectrometers based on ion mobility have been used to detect various chemical and biological compounds.
  • Such spectrometers include ion-mobility spectrometry (IMS) and differential ion mobility spectrometers (DMS) which are also known as field asymmetric waveform ion mobility spectrometers (FAIMS)
  • IMS ion-mobility spectrometry
  • DMS differential ion mobility spectrometers
  • FIMS field asymmetric waveform ion mobility spectrometers
  • TOF- IMS time-of-flight
  • the drift time is dependent on the mobility of ions in a low electric field based on size, mass and charge, and is characteristic of the ion species detected.
  • TOF-IMS has been used for detection of many compounds including narcotics, explosives, and chemical warfare agents, and at least one TOF-IMS system has been adapted for use in a field-portable device for detection of bacterial spores in the environment.
  • DMS devices offer an alternative to the low field TOF-F S ion mobility process.
  • ion filtering is achieved based on accentuating differences in mobility of ionized molecules in a high field. The high field mobility differences are used for "signature" identification of chemical species in an ionized sample.
  • DMS filtering is an efficient process, combining controlled neutralization of unselected ion species while passing selected ion species for detection.
  • Practices of the present invention are directed to methods and devices for detection and identification of analytes in samples using the mobility-based signature that is produced when a volatilized sample is passed through a differential ion mobility spectrometry (DMS) device.
  • DMS differential ion mobility spectrometry
  • Any volatized or volatilizable sample can be analyzed including organic, chemical, agricultural or biological samples.
  • the present invention includes using DMS to generate separation data and at least one other processing step that yields its own separation data. This additional separation step may be before or after DMS filtering. Analytes are reliably identified based on this combination of data.
  • the samples subjected to the analysis by the methods and devices of the present invention are either normally existent in the volatile state or require volatilization.
  • Analytes in a sample can be volatilized with or without fragmentation. Analyte volatilization and fragmentation can be achieved by any of the techniques known in the art including pyrolysis, thermodesorption, laser ionization, microwave heating or chemical transformation. Either prior to or following the volatilization, analytes in a sample can be additionally separated using any of the teclmiques known in the art such as gas chromatography. Each analyte is detected by its ion-mobility based signature. This signature is expressed as stored spectrometric data uniquely identifying the species being analyzed. The combination and relative abundances of various analytes in a sample forms a pattern that can be used to identify the entire sample by use of the stored reference data. Preferably the ion-mobility based signature is based on the differential mobility of that species as experienced in the compensated DMS filter field.
  • Analysis of physiological samples can identify diseases, monitor patient's condition or provide forensic information; analysis of environmental samples can detect chemical or biological contamination, including agents of chemical and biological warfare, or detennine geochemical composition of soil and sediments; analysis of food quality samples can detect bacterial and chemical contamination as well as early signs of decomposition; analysis of chemical samples can be used to monitor small and industrial scale processes as well as safety conditions; analysis of biological samples can be used to identify microorganisms in pure or mixed cultures as well as assess efficiency of medication or other antibiotic compounds; analysis of industrial samples can be used to monitor the quality of the material; analysis of agricultural samples can detect pesticides, herbicides as well as analyze soil and determine quality of crops.
  • one embodiment of the invention is directed to a method of detection and identification of analytes in a sample by an ion mobility based device, comprising (a) obtaining a volatilized sample comprising markers that are detectable by an aspect of ion mobility (preferably by DMS) ; and (b) directing at least a portion of the volatilized sample to a DMS detection device to obtain a mobility- based signature of at least one marker, wherein the mobility-based signature correlates with an analyte in the sample, thereby detecting and identifying at least one analyte in the sample.
  • a volatilized sample comprising markers that are detectable by an aspect of ion mobility (preferably by DMS) ; and (b) directing at least a portion of the volatilized sample to a DMS detection device to obtain a mobility- based signature of at least one marker, wherein the mobility-based signature correlates with an analyte in the sample, thereby detecting and identifying at least one ana
  • the present invention is a method of detection and identification of analytes in a sample, comprising (a) volatilizing at least a portion of the sample to produce a volatilized sample that includes markers detectable by an aspect of ion mobility; and (b) directing at least a portion of the volatilized sample to a DMS device, to obtain a mobility-based signature of at least one marker, wherein the mobility-based signature correlates with an analyte in the sample, thereby detecting and identifying at least one analyte in the sample.
  • the present invention is a device for analysis of samples (e.g., biological, chemical, organic, agricultural) using an aspect of ion mobility, comprising (a) a volatilization part; and (b) a differential ion mobility spectrometry (DMS) device connected to said volatilization part.
  • samples e.g., biological, chemical, organic, agricultural
  • DMS differential ion mobility spectrometry
  • the present invention is directed to a field asymmetric ion mobility detection system, comprising an input part and an output part, the input part including a volatilization part; at least a pair of spaced insulated substrates cooperating to define between them an enclosed flow path for the flow of ions from the input part to the output part; at least two electrodes opposite each other and defined in the flow path, the at least two electrodes including at least one filter electrode associated with each substrate to form an ion filter section; and an electronics part configured to apply controlling signals to the electrodes, and the electronics part applying an asymmetric periodic signal across the filter electrodes for filtering the flow of ions in the flow path, the filter being compensated to pass desired ion species out of the filter section.
  • the present invention is a method of detection and identification of analytes in a sample by an ion mobility-based device, comprising directing a portion of a sample into a first separation device thereby obtaining a first profile; directing a portion of a sample into a second separation device thereby obtaining a second profile, wherein at least one of the first and the second separation devices is a DMS device; and (c) combining the first and the second profiles thereby identifying at least one analyte in a sample.
  • the instant invention advantageously employs differential mobility spectrometry in a number of heretofore undisclosed industrial, clinical, diagnostic and environmental applications.
  • the methods and devices of the present invention enable rapid detection and identification of compounds. Such detection and identification can be made rapidly and with a high level of confidence.
  • Practices of the invention are sensitive to parts per billion and even parts per trillion levels.
  • embodiments of the invention can simultaneously filter and detect both positive and negative ions of an ion species.
  • Systems of the invention may be used alone or in combination with other analytical equipment with increased likelihood of accurate identification of chemical compounds, even at trace levels, and even for complex mixtures that heretofore have been difficult to resolve.
  • an inexpensive, fast and accurate chemical marker (including biomarker) analysis system which can even be provided in a compact and field-portable package.
  • FIG. 1 is a schematic flow diagram of an embodiment of the invention.
  • FIG. 2 A is a schematic diagram of a separation system of the invention.
  • FIG. 2B is a schematic diagram of an analysis system of the present invention.
  • FIG. 2C shows a detection scan according to the invention.
  • FIG. 3 is a schematic diagram of a separation system of FIG. 2A that includes an SPME pre-separator.
  • FIG. 4A is a schematic diagram of an embodiment of the present invention with a cylindrical arrangement of the electrodes of a DMS system.
  • FIG. 4B shows one embodiment of DMS electrodes where the electrodes are curved or curvilinear.
  • FIG. 5 is a schematic of an embodiment of the invention with a pyrolysis front-end.
  • FIG. 6 is a schematic diagram of an alternative separation method of the present invention.
  • FIG. 7 shows a mass-spectrometric analysis of pyrolysis products of the spores of B. subtilis.
  • FIG. 8 shows positive and negative ion spectra for picolinic acid in practice of the invention.
  • FIG. 9 shows positive and negative ion spectra for dipicolinic in practice of the invention.
  • FIG. 10 shows positive and negative ion spectra for pyridine in practice of the invention.
  • FIG. 11 A shows the full time-dependent DMS spectrum of pyrolyzed B. subtilis spores as a simulant for B. anthracis.
  • FIG. 1 IB shows the individual positive and negative ion spectra at 10 seconds after pyrolysis.
  • FIG. 12 shows spectra with putrescine and cadaverine resolved from one another in practice of the invention.
  • FIG. 13 shows background spectra with no sample present on a SPME fiber.
  • FIG. 14 shows spectra obtained from subject #1.
  • FIG. 15 shows spectra obtained from subject #2.
  • FIG. 16 shows spectra generated for markers for bacillus spore pyrolysis in practice of the invention.
  • FIG. 17 shows positive ion spectra for urine headspace detected in practice of the invention.
  • FIG. 18 shows spectra for a DMS embodiment of the invention with a GC front-end.
  • FIG. 19 shows spectra for the GC-DMS where the chromatographic runtime has been decreased leading to co-eluting species and showing that a practice of the invention is able to resolve the co-eluted species.
  • FIG. 20 shows comparison of prior art FID and a DMS embodiment of the invention for reproducibility for a homologous alcohol mixture.
  • FIG. 21 shows the results from py-GC-DMS characterization of positive ions for E. coli (A), M. luteus (B), and B. megaterium (C).
  • FIG. 22 shows the results from py-GC-DMS characterization of negative ions for E. coli (A), M. luteus (B), and B. megaterium (C).
  • FIG. 23 the profiles from py-GC-DMS analyses of E. coli, Lipid A and mixtures of Lipid A and E. coli.
  • FIG. 24 shows the compensation voltage versus retention time for the 50 peaks of highest intensity in py-GC DMS analyses of E. coli (grey signals) and M. luteus (black signals) for positive polarity ions.
  • FIG. 25 shows the compensation voltage versus retention time for the 30 peaks of highest intensity in py-GC-DMS analyses of E. coli (grey signals) and M. luteus (black signals) for negative polarity ions.
  • FIG. 26 shows the effect of separation voltage on py-GC/DMS characterization of B. megaterium in positive polarity.
  • FIG. 27 shows the effect of temperature on py-GC/DMS characterization of B. megaterium in positive polarity.
  • FIG. 28 shows the Peak area versus number of bacteria for B. megaterium
  • FIG. 29 shows overlapping prior art TOF-IMS spectra for m-Xylene and p- Xylene isomers.
  • FIG. 30 shows resolved DMS spectra for m-Xylene and p-Xylene.
  • FIG. 31 shows positive ion spectra for different concentrations of methyl salycilate.
  • FIG. 32 shows concentration dependence of the invention to methyl salycilate for both positive and negative ion spectra.
  • FIG. 33 shows total ion chromatograms from GC-MS analysis of emissions of organic compounds trapped on SPM ⁇ fibers by sampling plumes from combustion of several materials.
  • FIG. 34 shows mass spectra from direct characterization of grass, cotton and cigarette smoke using atmospheric pressure chemical ionization mass spectrometry.
  • FIG. 35 shows plots of total intensity of product ions versus retention time from GC-DMS characterization of emissions of organic compounds trapped on SPM ⁇ fibers in plumes from combustion of cotton, paper and grass.
  • FIG. 36 shows plots of total intensity of product ions versus retention time from GC-DMS characterization of emissions of organic compounds trapped on SPME fibers in plumes from combustion of cigarette and engine exhausts. Plots can be compared directly to FIG. 35.
  • FIG. 37 shows topographic plots from GC-DMS characterization of emissions of organic compounds trapped on SPME fibers in plumes from combustion of cotton and paper.
  • FIG. 38 shows topographic plots from GC-DMS characterization of emissions of organic compounds trapped on SPME fibers in plumes from combustion of grass and gasoline.
  • FIG. 39 shows plots of ion chromatograms extracted from analyses by GC- DMS of emissions from combustion of cotton (top frame) and paper (bottom frame). Ion chromatograms were extracted from plots in FIG. 37.
  • FIG. 40 shows plots of ion chromatograms extracted from analyses by GC- DMS of emissions from combustion of grass (top frame) and from engine exhausts (bottom frame), as extracted from plots in FIG. 38.
  • FIG. 41 shows resolution of a nerve gas and an interferant simulants at different radio frequency field strengths by a DMS device of the present invention.
  • FIG. 42A and FIG. 42B show DMS spectra of both positive and negative ion peaks, or modes, for a nerve agent stimulant GA.
  • FIG. 43 shows the effect of reduced pressure on resolution of various peaks by a DMS device of the invention. Resolution increases when pressure is decreased.
  • FIG. 44 demonstrates a practice of the invention for a series of warfare agent simulants selectively mixed with 1% headspace of aqueous fire fighting foam. As can be seen, good peak resolution can be achieved in practice of the invention.
  • the present invention is directed to methods and devices for detection and identification of analytes in chemical, biological, agricultural or organic samples using characteristic mobility-based behavior of the volatilized sample as it is passed through a differential ion mobility spectrometry (DMS) device of the invention.
  • This characteristic behavior is also referred to herein as a signature, by means of which ion species can be separated, detected and identified in practice of the invention, hi preferred practices, this signature is ion-mobility based and detected in gas-phase DMS.
  • each analyte is detected at least by its ion-mobility based signature.
  • DMS species identification is done by making a species detection and comparing this data to stored data which uniquely identify a species based upon aspects of ion mobility, i.e., differential mobility.
  • the data may include field conditions (e.g., wavelength, frequency, intensity, among others), compensation voltage (a DC offset, or variations in the RF signal, such as changes in duty cycle, among others) and also may include flow characteristics (such as flow rate or field gradient, among others) and temperature.
  • DMS produces a signature representing differences in ion mobility between high field and low field conditions.
  • a signature used in the methods of the present invention is the combination of the compensation voltage and a field strength that results in a known spectral output associated with the species being analyzed.
  • time of flight ion mobility is used to further characterize aspects of a detected ion species to further assist species identification.
  • Differential ion mobility spectrometry is a technique for ion separation, detection and identification.
  • An asymmetric varying high RF field is established between filter electrodes over a flow path. Ions in the flow path are driven by the field transversely and eventually are neutralized as they contact the electrodes.
  • ions derived from two compounds respond differently to the applied high strength electric field, the ratio of high to low field mobility may be different for each compound. Consequently, the magnitude of the compensation necessary to counteract the drift of the ions toward either plate is also different for each ion species.
  • DMS digital tomography
  • the present invention may be practiced with various configurations.
  • Preferred embodiments feature compact and field-portable, wide-spectrum, dual mode, DMS systems, such as taught in U.S. application number 10/123,030, U.S. provisional application number 60/389,400, as well as the device described in U.S. Pat. Nos. 6,495,823 and 6,512,224 and in copending U.S. Application Serial No. 10/187,464, filed 06/28/02, and U.S. Application Serial No. 10/462,206, filed 06/13/03.
  • the entire teachings of the above-referenced disclosures are incorporated herein by reference.
  • the methods of the present invention can be used to analyze any volatile or volatilizable sample.
  • volatile means evaporating readily at normal temperatures and pressures.
  • volatilizable means capable of being converted into gas by use of any of the volatilization methods known in the art.
  • volatilization refers to a process of conversion of solid or liquid to a gas. hi some embodiments, purification, fractionation and/or separation of a sample is desired prior to collection of volatile components or volatilization of a sample or a part thereof.
  • Samples can be optionally purified or separated before beginning the DMS analysis by any of the standard techniques known in the art such as HPLC, turbulent flow chromatography, liquid chromatography, reverse phase chromatography, affinity chromatography, supercritical fluid chromatography, gas chromatography (GC), electrophoresis (including but not limited to capillary electrophoresis, polyacrylamide gel electrophoresis, agarose gel electrophoresis), solid phase extraction, and liquid phase extraction, preferably using different solvents (e.g., chloroform/methanol for lipids, water for polar molecules).
  • the capillary of the ion source could be filled with silica beads (derivatized or not) or other material to perform chromatography and/or separation.
  • Volatile or volatilized components can further be separated into fractions by any technique known in the art, for example, gas chromatography (GC), desorption/absorption, effusion, condensation, filtration, ion exchange, or the like.
  • the sample contains volatile components.
  • a volatile sample can be collected from the source by collecting headspace or any other technique known in the art such as filtration, distillation, sublimation, vacuum distillation, etc.
  • Volatile or volatilized components can be directly subjected to DMS analysis or further separated using any of the techniques as described herein.
  • the volatile components are filtered through a membrane to reduce moisture content and other impurities that may affect signal-to-noise ratio.
  • Membrane materials can include, for example, polymers such as Teflon or dimethyl silicon.
  • samples do not contain volatile components or may contain a combination of volatile and nonvolatile components.
  • these samples can be subjected to gas-phase DMS analysis as long as they are volatilizable.
  • samples of body tissues, pathogens, building materials or samples of soil may not be volatile, but are volatilizable.
  • breath can contain both volatile components and non-volatile but volatilizable components.
  • the whole sample or any fraction thereof can be subjected to volatilization.
  • Volatilization can be performed in the presence or absence of an oxygen environment.
  • volatilization produces a complex mixture of chemicals referred to herein as "markers".
  • Markers can include whole molecules or fragments thereof.
  • the composition and relative abundance of the markers in a volatilized sample uniquely identifies the sample.
  • Such sample may be organic or inorganic, chemical, biological or otherwise.
  • any of the techniques known in the art can be used for volatilization.
  • sufficient energy is applied to a sample to break intra- or inter-molecular chemical bonds of the analytes in the sample.
  • Non-limiting examples include pyrolysis, thermal desorption, including temperature-programmed desorption and thermally assisted solid phase micro-extraction (SPME), laser ionization, including matrix assisted laser desorption ionization (MALDI), microwave excitation (heating with microwaves), and chemical transformation (e.g., hydrolysis, photolysis, oxidation, etc.).
  • pyrolysis refers to a procedure in which a material is heated, usually in the absence of oxygen, thereby causing the material to break down into simpler compounds.
  • Pyrolysis provides a volatilization technique for various types of sample analysis, especially for samples that are not easily volatilized. Pyrolyzing a sample produces a complex mixture of volatile, semi- olatile and non- olatile organic chemicals (herein referred to as pyrolysate). Vapors generated during pyrolysis can be swept directly into a detection device.
  • the composition and relative abundance of various components in the pyrolysate is a unique characteristic of a given sample. Accordingly, the sample can be characterized by analyzing pyrolysis products using DMS to produce a "fingerprint," i.e., signature, that can uniquely identify the sample.
  • thermal desorption Another method for volatilization of a sample is thermal desorption, which is a widely used technique for extracting and isolating volatile and semi-volatile compounds from various matrices.
  • samples usually solids, are heated and analytes are volatilized.
  • a carrier gas or vacuum system transports the volatilized components to a detection device.
  • thermal desorption processes can be categorized into two groups: high temperature thermal desorption (HTTD) (320 to 560°C or 600 to 1000°F) and low temperature thermal desorption (LTTD) (90 to 320°C or 200 to 600°F).
  • HTTD high temperature thermal desorption
  • LTTD low temperature thermal desorption
  • TPD Temperature programmed desorption
  • SPME solid phase micro- extraction
  • SPME is a technique of pre-concentration of analytes whereby the analytes of interest are extracted from a sample by absorption into solid phase material, usually fibers. Absorption of the analytes by the fibers is based on the affinity and solubility of the analytes in the solid phase material of the fibers.
  • Solid phase materials can include various polymers, for example, polyacrylate, polydimethylsiloxane, divinylbenzene and mixtures thereof.
  • Analytes can be extracted from either gas or liquid phases. Alternatively, a solid sample can be subjected to thermal desorption and the volatile analytes released during this process can be absorbed by SPME fibers, thus pre-concentrating the analytes of interest.
  • the compounds are thermally desorbed by a pre- programmed temperature ramping and directed for analysis and detection.
  • a suitable TPD/SPME device is disclosed in Basile, F., Instrumentation Sci. Tech. 31(2): 155-164 (2003), the entire teachings of which are herein incorporated by reference.
  • MALDI is a method that allows for vaporization and ionization of non- volatile samples from a solid-state phase directly into the gas phase at atmospheric pressure or in vacuum. Briefly, the technique involves mixing the analyte of interest with a large molar excess of a matrix compound, usually a weak organic acid. This mixture is placed on a vacuum probe and inserted into a detection device for laser desorption analysis. During laser desorption, the matrix that also contains the analytes is irradiated with lasers in order to transfer the content into the gas phase. The matrix strongly adsorbs the laser light at a wavelength at which the analyte is only weakly absorbing.
  • a matrix compound usually a weak organic acid
  • the matrix reduces intermolecular contacts beyond analyte-matrix interactions thereby reducing the desorption energy.
  • the results are high ion yields of the intact analyte and giving rise to sub-picomole sensitivity.
  • Principles of MALDI are well-known in the art.
  • MALDI devices suitable for use with the present invention are described, for example, in U.S. Pat. Nos. 6,414,306 and 6,175,112, the entire teachings of which are herein incorporated by reference.
  • the whole sample or any analyte in a sample can be subjected to volatilization.
  • the markers produced by volatilization of a sample are separated using any of the standard separation techniques used in the art, for example, gas chromatography. Following chromatographic separation, any or all fractions can be subjected to DMS-based detection.
  • samples can be derived from any source and can include physiological, environmental, biological, chemical, agricultural and industrial sources.
  • Physiological samples such as breath or tissue samples or physiological fluids (including blood, urine, synovial fluid, saliva, etc.) can be used to diagnose and monitor patient conditions, including point of care patient monitoring, and provide forensic information.
  • Environmental samples such as air, soil, sediments, petroleum, natural gas or water can be used to detect chemical or biological contamination, including that by heavy metals, and in monitoring of remediation sites, berms, incinerator wastes and water treatment facilities.
  • Methods of the present invention can be used for detecting agents of chemical and biological warfare in a sample.
  • Food quality samples such as foodstuff, air samples from refrigerators or containers, and swabs of food-contacting surfaces, can be used to detect bacterial and chemical contamination of as well as early signs of decomposition during shipping, in monitoring shelf life and/or package tampering.
  • Chemical samples such as samples of reaction mixtures, can be used to monitor small and industrial scale processes, including the extent of reactions and detection and separation of stereoisomers, as well as to monitor safety conditions.
  • Biological samples such as samples of pathogens, can be used to identify microorganisms in pure or mixed cultures as well as assess efficiency of medication or other antibiotic compounds.
  • Industrial samples such as samples of medicaments, sample of cosmetic products, samples of building materials, samples of crop plants, fabric, synthetic polymers and organic materials, can be used to monitor the quality and integrity of the material.
  • the sample includes whole microorganisms, non- microbiotic pathogens or other biological materials.
  • a sample can include protozoan, fungal, bacterial or viral infectious agents, antibodies and other proteins, nucleic acids, peptides, peptidomemetics, peptide-nucleic acids, oligonucleotides, aptamers, lipids, polysaccharides, liposaccharides, lipoproteins, glycoproteins, and small molecules.
  • the sample contains infectious agents and microorganisms such as protozoa, fungi, bacteria and virus.
  • IMS ion mobility spectrometry
  • IMS can be used prior to, following or in parallel with the DMS analysis.
  • the use of IMS can aid and/or supplement DMS analysis in some cases.
  • an IMS device can be used as an ion filter to additionally separate and filter the analytes of the sample or the volatilized markers and/or analytes, thus raising sensitivity and signal-to-noise ratio of the DMS device and its detectors.
  • a given sample can be subjected to an IMS analysis in parallel with a DMS analysis.
  • IMS spectra can be compared to those obtained by a DMS device. By comparing the two types of spectra, additional information useful in analysis and identification of the markers and analytes can be obtained.
  • the present invention is a method of sample identification, wherein a sample is analyzed and the analytes contained therein identified by a multi-stage process that includes differential mobility analysis, hi one embodiment, a first stage of sample processing can include filtering a sample by particle size, a second stage can include volatilization and the next stage can include differential ion mobility. In another embodiment, the present invention is a method of analysis of complex mixtures that includes coupled Ion Mobility/Multiple Stage Mass Spectrometry.
  • the present invention can be used in the identification of microorganisms, in clinical, research, industrial, and public health applications, including terrorism.
  • the invention is useful in diagnosing bacterial, viral, fungal and protozoan diseases and infections affecting particular patients.
  • Patients can be human, primates, companion animals (dogs, cats, birds, fish etc.), livestock (cows, sheep, fish, fowl and poultry, etc.).
  • the present invention can be used for pathogen identification in mixed cultures, without the need for isolating and culturing of the microorganisms. Briefly, a sample of infected tissue, a physiological fluid from a patient or a sample of a pathogen culture is volatilized.
  • the pathogen culture can be mixed, i.e., contain more than one type of microorganisms.
  • the volatilized sample is directed to a DMS detection device of the present invention. Because the volatilized sample comprises markers unique to the pathogens in the sample, the pathogens are identified, hi an alternative embodiment, volatile compounds emitted by the organisms (methane, ammonia, ethylene, plant alkaloids as well as oxygen, carbon dioxide, products of amino acid decarboxylation, protein and lipids decomposition) can be detected to assess cell growth and death as well as other physiological changes.
  • a suitable separation techmque known in the art, such as gas chromatography
  • the methods of the present invention are used in the rapid identification of antibiotic resistant strains of organisms such as Staphylococcus aureus and Mycobacterium tuberculosis, and may optionally be used to determine to wliich antibiotics or combinations of antibiotics the particular strain of bacterium infecting the patient is susceptible. Additionally, the invention is useful in distinguishing between diseases with similar clinical manifestations but different causative agents, with possible differences in the preferred course of treatment.
  • the invention can be used in the identification of pathogenic and non-pathogenic fungi, as well as determining which agents are effective against fungal infections.
  • Both the systemic disease caused by primary pathogens such as Histoplasma capsulatum and the opportunistic mycoses caused by Candida albicans or Cryptococcus neoformans can be detected using methods of the present invention.
  • Assessment of the type of infectious agent can lead to better methods for treatment.
  • the invention is useful in the diagnosis of at least some of the protozoan parasites, and especially those, such as N fowleri, which require culturing for definitive diagnosis.
  • the invention is also useful in the determination of appropriate treatment of an infection by any parasite.
  • Plasmodium falciparum the organism associated with the majority of the one to two million deaths annually from malaria, has developed resistance to chloroquine, the first-line agent used in treatment.
  • chloroquine the first-line agent used in treatment.
  • the invention can be used to determine to which agents the parasites infecting an individual show susceptibility.
  • the present invention can be used in the diagnosis of viral diseases, as well as the determination of agents to which particular viruses show susceptibility.
  • viruses which can be identified using the DMS analysis of the present invention include: Herpesviruses, which infect vertebrates, including humans (Varicella-Zoster (chickenpox, shingles), Epstein-Barr and Cytomegalovirus (infectious mononucleosis), Herpes Simplex (herpes, Kaposi's sarcoma); Baculoviruses, which infect invertebrates (especially insects such as silk worms); iridovirus, which causes African swine fever; Poxviruses, which infect invertebrates and vertebrates, including humans causing Variola (smallpox), Vaccinia, Monkeypox, Mousepox; adenovirus, which infect vertebrates, including humans and causes colds; caulimoviruses, which infect plants; papillomavirus, which causes warts and other tumors; bacterioph
  • the methods of present invention can further be used in determination and diagnosis of animal and human disease such as Creutzfeld- Jacob disease, scrapie and mad cow disease, where the infectious agent is a conformer of a wild-type analog.
  • the present invention can be used for public health monitoring.
  • the presence of coliforms, such as E. coli, in waters off beaches is often used as a marker for the presence of untreated sewage.
  • the invention can be used in testing of water samples to determine whether coliforms are present, without first having to isolate and culture the various microorganisms in the sample. Volatilization of a mixed bacterial sample produces markers unique for each microorganism in a sample, hi another example, the invention can be used to determine the presence of Cryptosporidium or Vibrio cholerae in water supplies.
  • the invention can be used for testing of municipal water supplies and other waters for the presence of these and other pathogens.
  • the invention can further be used in the determination of which chemical agents are effective against the particular organism or strain of organism infecting a particular patient. Briefly, a time series of samples of infected tissue, a physiological fluid or samples of a mixed pathogen culture from a patient being administered a specific chemical agent are analyzed using aspects of ion mobility as described herein. The methods of the present invention can identify which of the pathogens responds to the selected treatment. Thus, the invention can be employed in screening novel chemical compositions as antibiotics for their potential efficacy as agents to kill or inhibit the growth of microorganisms. In general, screening typically involves dividing cultures of the organism into multiple aliquots.
  • the agents being tested are then introduced into a first group of the aliquots, while a second aliquot is reserved as a control to which no agent is added.
  • the relative amounts of the organisms in the first test group are then compared to the amounts of the organisms grown in the presence of the agents in the second, control group so that the relative effectiveness of the agents being tested can be determined.
  • Large numbers of aliquots can be cultured and tested in parallel, permitting the testing of large numbers of potential agents to be tested at once. Due to high sensitivity of the methods of the invention, this embodiment can be particularly beneficial where large scale culturing of microorganisms is to be avoided.
  • microorganism assays employed by the methods of the present invention will now be described.
  • the methods described below will be directed toward bacteria, although fimgi, protozoa and viruses can be employed with modifications familiar to persons of skill in the art.
  • a specimen to be subjected to analysis for example blood, urine, mouth or vaginal swab, personal odor, or a sample of food or of water believed to contain a pathogen (e.g. virus, bacteria, fungi or protozoa) is obtained.
  • a pathogen e.g. virus, bacteria, fungi or protozoa
  • the specimen is usually suspended in an aqueous medium prior to being subjected to the process of this invention.
  • the size of the sample is not critical, provided a sufficient number of microorganisms are obtained to permit the intended procedures to be performed. Further, the numbers of bacteria present in the aqueous suspension are not critical, provided a sufficient number of bacteria are present for the procedure of this invention to detect differences between test and control samples.
  • the time required to perform the analysis can be reduced as the concentration of microorganisms increases.
  • the specimen may be concentrated by known techniques, such as centrifugation or by culturing.
  • the specimen is cultured by incubating under conditions suitable for sustaining bacterial growth. The period of incubation is that period sufficient to obtain detectable growth, which will differ depending upon factors such as bacterial species and concentration of organisms in the sample.
  • the specimens are volatilized and quantitatively and qualitatively analyzed using ion mobility detection devices of the present invention.
  • Analysis of physiological fluids and other biological samples by the methods of the present invention can be done by employing any of the volatilization procedures described herein, hi one embodiment, the volatile components of a sample are analyzed by collecting the volatile analytes at a headspace of a liquid or solid sample. In another embodiment, a liquid or solid sample can be volatilized as described herein. Samples can be obtained from a variety of sources.
  • the sources comprise any number of things, including, but not limited to, cells (including both primary cells and cultured cell lines), tissues and bodily fluids (including, but not limited to, blood, urine, serum, lymph, bile, cerebrospinal fluid, interstitial fluid, aqueous or vitreous humor, colostrum, sputum, amniotic fluid, saliva, anal and vaginal secretions, perspiration and semen, a transudate, an exudate (e.g., fluid obtained from an abscess or any other site of infection or inflammation) or fluid obtained from a joint (e.g., a normal joint or a joint affected by disease such as rheumatoid arthritis, osteoarthritis, gout or septic arthritis) of virtually any organism.
  • cells including both primary cells and cultured cell lines
  • tissues and bodily fluids including, but not limited to, blood, urine, serum, lymph, bile, cerebrospinal fluid, interstitial fluid, aqueous or vitr
  • Samples can be obtained, for example, from plants (e.g., crops), invertebrates (e.g., silk worms), non-mammalian vertebrates (e.g., poultry, fish, exotic birds, fowl), non-human mammals (e.g., livestock, companion animals, primates) and humans. Samples can also be collected from extracellullar fluids, extracellular supematants from cell cultures, inclusion bodies in bacteria, cellular compartments, cellular periplasm, mitochondria compartment, etc.
  • the preparation of samples for the DMS-based analysis can be achieved by any method known to those of skill in the art. Sample preparation can include a desalting step to increase the sensitivity and resolution.
  • the combination of preparative steps, solvents, purification and separation schemes will all depend on the class(es) of molecules expected to be detected.
  • Samples can be prepared in a variety of ways. One skilled in the art will readily determine the manner of sample preparation, which depends, generally on the source and the type of analytes expected to be detected.
  • physiological fluid samples can be prepared by a protein precipitation followed by a desalting treatment. A solution of methanol and water (49:49:2 water :methanol: acetic acid v:v:v) is added to each of the samples and the samples are chilled. This precipitates the proteins to the bottom of the tube. Each tube is then centrifuged and the supernatant decanted.
  • small amount (approximately 100 mg) of DOWEX ion exchange resin is added to each vial and allowed to sit for approximately 10 minutes.
  • the sample is then centrifuged and the supernatant removed. This solution is then introduced to the an ion-mobility detection device.
  • Any solvent known to those of skill in the art can be used in conjunction with an ion source in the practice of the present invention.
  • suitable solvents are dimethylsulfoxide, acetonitrile, N,N-dimethyl formamide, propylene carbonate, methylene chloride, nitromethane, nitrobenzene, hexane, methanol and water.
  • the solvent can comprise more than one solvent.
  • the solvent is a solution of methanol and water (49:49:2, water:methanol: acetic acid v:v:v).
  • a suitable solvent will depend on the type of molecules is expected to be detected. For example, a solution of methanol and water is used as a solvent when the detection of soluble molecules is to be achieved by the ion- mobility device, while hexane can be used when the detection of apolar molecules such as lipids is to be achieved, hi one embodiment of the invention, the sample source (e.g., tissues, cells) is extracted in different solvents and each extraction subjected to analysis, so that a more complete analysis of the molecules present in the sample source can be accomplished.
  • a solution of methanol and water is used as a solvent when the detection of soluble molecules is to be achieved by the ion- mobility device
  • hexane can be used when the detection of apolar molecules such as lipids is to be achieved
  • the sample source e.g., tissues, cells
  • each extraction subjected to analysis so that a more complete analysis of the molecules present in the sample source can be accomplished.
  • Samples can optionally be purified, fractionated and/or separated using any of the standard technique known in the art as described herein.
  • purification and separation techniques may be simultaneously or sequentially run on samples, in different orders and in different combinations.
  • a simple protein precipitation may be run on a portion of the sample, and then a HPLC step.
  • portions of samples e.g., portions of the cellular populations
  • An embodiment of the present invention provides a method of urinalysis using aspects of DMS ion mobility of the urine constituents.
  • Urinalysis is an examination of the urine by physical or chemical means.
  • Urinalysis comprises a battery of chemical and microscopic tests that help to screen for urinary tract infections, renal disease, and diseases of other organs that result in abnormal metabolites appearing in the urine.
  • bilirabin a degradation product of hemoglobin
  • glucose an indication of hemolysis
  • urine ketones a by-product of fat metabolism and present in starvation and diabetes
  • nitrite an indication of urinary tract infection
  • urine pH the acidity or alkalinity of the urine
  • urine protein urobilinogen (a degradation product of bilirabin).
  • pathogens such as fungi (yeasts), protozoa, bacteria and viras can be detected.
  • an alkaline urine is good. Kidney stones are less likely to form and some antibiotics are more effective in the alkaline urine. There may be times when the acidic urine may help prevent some kinds of kidney stones and may prevent growth of certain types of bacteria. When blood levels of glucose are very high, some of the glucose may show up in the urine. The glucose and the ketones tests are usually done together. Large amounts of ketones may be present in uncontrolled diabetes. Finding protein in the urine is probably the best test for screening for kidney disease, although there may be a number of causes for an increased protein level in the urine. Bilirabin in the urine is a sign of a liver or bile duct disease.
  • Urobilinogen is found in small traces in the urine. Nitrites and white blood cells are an indication that a urinary tract infection is present. Any vitamin C that the body does not need is excreted in the urine. If there are measurable amounts of Vitamin C in the urine, it may interfere with the other urine tests. Volatile components of a urine sample are colected by directing a headspace to a DMS detection device.
  • urine sample is subjected to gas-chromatographic separation prior to DMS analysis, hi an exemplary procedure, a gas chromatograph is maintained at an initial temperature designated as To. At the onset of analysis, designated as time to, the sample is introduced to the inlet of the gas chromato graph column.
  • the temperature of the gas chromatograph is then elevated or ramped at a constant rate to a temperature T r , reached at time t r at which all analytes have completed elution from the column.
  • the column is further heated to a final temperature T f , slightly elevated above T r , at time t ls and is held at this temperature to clean out the column.
  • the chromatograph is cooled back down to the initial temperature T 0 for subsequent analysis, which cooling down is completed at a time t 3 .
  • Every person emits a particular chemical odor which may be used as a signature.
  • This odor signature can be detected by DMS practices of the invention.
  • the odor signature can be used to identify an individual for security applications, to identify bodies, and for covert applications to dete ⁇ nine if a terrorist has been residing in a particular location based on signatures from urine or other residual odors left at the location.
  • signature detection based on detection of volatile chemicals, may be practiced according to the present invention.
  • An embodiment of the present invention provides a method of breath analysis.
  • the present invention provides a method and apparatus that can measure and analyze both volatile and relatively non- volatile components released. Alcohols, such as ethanol, can be detected in exhaled air. Furthermore, understanding the composition of breath analysis can be used to diagnose diseases and elucidate pharmacokinetic properties of various compounds.
  • Alveolar breath is a distinctive gas whose chemical composition differs markedly from inspired air.
  • Volatile organic compounds are either subtracted from inspired air (by degradation and or excretion in the body) or added to alveolar breath as products of metabolism.
  • Normal human breath contained several hundred different VOCs in low concentrations. More than a thousand different VOCs have been observed in low concentrations in normal human breath.
  • Alkanes in breath are markers of oxygen free radical (OFR) activity in vivo.
  • OFR's degrade biological membranes by lipid peroxidation, converting polyunsaturated fatty acids to alkanes which are excreted through the lungs as volatile organic compounds (VOCs); (Kneepkens C. M. F., el al, The hydrocarbon breath test in the study of lipid peroxidation; principles and practice, Gin. Invest. Med. 1992; 15(2):163-186).
  • VOCs volatile organic compounds
  • the cytochrome P450 (CYP) system comprises a group of mixed function oxidase enzymes which metabolize drugs and other xenobiotics. This system also metabolizes alkanes to alcohols e.g. n-hexane to 2- and 3-hexanol.
  • the cytochrome P450 system is reportedly expressed in cancers of breast as well as other tissues (Murray G. I., et al, Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 1997; 57(14):3026-31). Recent studies suggest that exhaled pentane can be used as an additional marker for breast cancer.
  • Hietanen et al. studied 20 women with histologically proven breast cancer and a group of age and sex-matched controls Hietanen E., et al, Diet and oxidative stress in breast, colon and prostate cancer patients: a case control study, European Journal of Clinical Nutrition 1994; 48:575-586.
  • the methods and devices of the present invention can be particularly useful in diagnosing ischemic heart disease.
  • Methods of the present invention can be used as non-invasive techniques to diagnose organ rejection, including heart.
  • organ rejection including heart.
  • biochemical basis for breath testing that provides for the early detection of transplant rejection.
  • Tissue damage arising from inflammation is accompanied by an accumulation of intracellular oxygen free radicals (OFR'S) which cause lipid peroxidation of lipid membranes (Kneepkens C. M. F., et al, The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. Gin Invest Med 1992; 15(2):163-186.
  • End-stage renal disease is a fatal condition unless it is treated with either kidney transplantation or dialysis of blood or peritoneal fluid.
  • Clinicians who come into contact with patients with chronic renal failure are familiar with the classic odor of uremic breath. It has been variously described as “fishy”, “ammoniacal” and “fetid”. This odor arises from presence of trimethylamine and dimethylamine in the blood, as well as increased concentrations of secondary and tertiary amines. Methods of the present invention can be used to detect these compounds, thus indicating the presence of ESRD.
  • the present invention is a breath test which can be used to determine the characteristic of metabolism of a drag in a subject.
  • the present invention can be used to dete ⁇ nine this characteristic of metabolism by measuring the concentration of a metabolite in the exhaled breath of the subject after an appropriate amount of the drug has been administered to the subject.
  • characteristic of metabolism includes whether such metabolism occurs, the rate of metabolism and the extent of metabolism. However, for clarity the aforementioned and following descriptions specifically describe the measurement of the rate of metabolism.
  • these tests involve the adminisfration of a substrate to the subject and the measurement of one or more cleavage products produced when the substrate is chemically cleaved.
  • detecting Helicobacter pylori which produces a large quantity of the enzyme urease, can be accomplished by orally administering urea to a subject with subsequent monitoring of the exhaled dioaxide and ammonia.
  • Breath tests can be used to measure physiological processes such as the rate of gastric emptying.
  • gastric emptying rates were measured for solids and liquids by using octanoate or acetate as the substrate (Duan, L.-P., et al, Digestive Diseases and Sciences, 1995, 40:2200-2206).
  • the substrate can be administered to the subject and the exhaled breath of the subject was measured with an ion-mobility detection device.
  • the breath test of the present invention can be performed as follows. First, the drug is administered to the subject. Next, the exhaled breath of the subject is analyzed after a suitable time period for a concentration of a metabolite of the drug, the concentration indicating the rate of metabolism of the drug in the subject.
  • a breath test has a number of advantages over conventional methods for determining the concentration of a drug in the subject. Not only is a breath test non-invasive, it is also more rapid than analyzing blood samples and it can also be performed multiple times on the subject.
  • the present invention provides a method and apparatus that can measure and analyze components released from food or other products during oral processing. An optional step of volatilization is employed should detection of non- volatile components is desired. This method can be used to measure components that are present in small concentrations, yet are important to the flavor of a product.
  • the collection system included a mouthpiece and a tube for carrying the exhaled breath of the subject into a mixing chamber.
  • a sample outlet and exit tube connected the mixing chamber to a measuring device, such as DMS detection device, hi addition, heat can be applied to the system to prevent condensation of moisture from the breath sample on the system components.
  • the mixing chamber can be provided to insure that the exhaled breath sample mixed with previous samples, and that a small quantity of the combined breath sample was drawn from the chamber into the measuring device.
  • the collection system uses a pumping system to draw an air sample from the nose of a subject, through a nose-piece and past a membrane separator fitted to a DMS detection device.
  • a carrier gas e.g. N 2
  • a breath sample can be injected into a separating column, e.g. GC, and then circulated toward an ion- mobility detection device.
  • a separating column e.g. GC
  • the subject exhales a breath sample into one or more collection chambers that are preferably maintained in a temperature controlled cabinet to prevent condensation of portions of the sample. Either mouth-exhaled or nose-exhaled air can be collected. Where food flavorings are being detected, samples are preferably collected from the subject's mouth.
  • Each breath sample can be purged from its collection chamber with a non-reactive gas flow into a trap containing an interface that separates and collects components from the breath sample.
  • This interface preferably is an inert adsorbent material selected for its ability to.
  • a substrate coated with an absorbent or other material capable of collecting components may also be used.
  • the interface in addition, preferably permits any moisture contained in the breath sample to pass through the trap, leaving only the collected components on the interface.
  • the adsorbent trap is then transferred to a thermal desorber or other device capable of releasing the adsorbed components from the interface surface into a measuring and analysis apparatus, such as an ion-mobility based detection device of the invention.
  • the components collected by an adsorptive trap are thermally desorbed from the trap and flushed into a gas chromatograph by a non- reactive gas flow prior to being identified by an ion-mobility detection device.
  • the subject blows each breath sample first through a condensation trap and then into the collection chamber.
  • the condensation trap captures relatively non- volatile flavor components that might not otherwise be recovered from the collection chamber or could not, be readily desorbed from an adsorbent trap.
  • the condensation trap preferably includes non-reactive glass tubing packed with a non-reactive and non-adsorbent substrate, such as glass wool. Other materials may be used provided that the materials withstand high temperatures and do not react with flavor compounds.
  • the trap is maintained at a temperature that will encourage the condensation on the substrate of slightly volatile or relatively nonvolatile flavor components in the subject's breath and permits the volatile components to pass through into the collection chamber.
  • the condensation trap is then heated to re-vaporize the condensed components, so that they may be purged into measuring and analysis devices such as a gas chromatograph and mass measuring device.
  • measuring and analysis devices such as a gas chromatograph and mass measuring device.
  • the flavor components that passed through the condensation trap into the collection chamber also may be flushed into an adsorbent trap so that they may be studied as discussed above.
  • the present invention can be used in the detection of chemical contaminants and/or viable pathogens that may be present in processed foods, such as found in ground beef and other meats.
  • the ability to rapidly confirm or disprove the presence of significant contamination may, for example, reduce or eliminate the need for destruction or recall of ground meats or other foods in cases where contamination was possible but not certain by demonstrating that the meats or other foods in question are not contaminated with viable bacteria at the time of testing.
  • the present invention can be used in food processing plants, hospitals, laboratories, and other facilities to detennine whether surfaces are free of pathogens or whether additional or more stringent sterilization or containment procedures are required. This can be achieved by, for example, collecting a sample of dust or a cotton swab of a surface in question, followed by either re-suspending the sample material in a fluid or immediate volatilization. The volatilized sample is subjected to detection as described herein.
  • the present invention can further be used to identify contaminated food containers by collecting either a sample of a headspace or a swab of a surface.
  • the present invention can be used for detection of substances in a foodstuff industry. Both odorous (relatively volatile) and non- odorous substances (relatively non-volatile) can be detected, the latter with an additional optional step of volatilization being required before the sample being directed into a DMS device.
  • a method for detecting odorous or volatile substances or substances made volatile comprises the steps of directing an air sample collected in the proximity of a food substance or a food-handling surface to DMS detection device.
  • This method can advantageously employ sample collection techniques described in U.S. Pat. No. 5,801,297. h particular, the transport of the odorous substances from a sample can be achieved by a variable controlled flow of gas. This allows for very rapid detection of odorous substances, in about a few seconds.
  • the means used in order to achieve this variable controlled flow of gas are advantageously made up of at least a pump with variable flow rate. During the phase of separating and detecting the components of a sample, the gas flow rate can be diminished or increased according to whether the substances become more or less volatile throughout the duration of the measurement period.
  • SMART DMS SMOKE DETECTOR The present invention can be used for identification of a fuel source by analyzing smoke. Where a gas chromatography device is used to pre-separate the smoke components, GC-DMS instrument operating at ambient pressure in air provides a compact and convenient fuel-specific smoke alarm at a reasonable cost. The specificity and sensitivity of the system earns the moniker of a "smart DMS smoke detector".
  • One embodiment of the present invention provides a smart smoke detector with high specificity by detection of volatile organic constituents (VOCs) in the smoke.
  • VOCs volatile organic constituents
  • Fires produce a large number of organic compounds in complex mixtures in the vapor phase as seen in fires from synthetic polymers, cigarettes, and cellulose- based materials such as wood or cotton. This approach provides sufficient analytical information for selective detection of fire components through measurement of the chemical composition of the emissions.
  • FIG. 1 An illustrative practice of the invention is shown as system 10 in FIG. 1, in which a sample A and transport fluid B are delivered to a filter C (operating by aspects of ion mobility), wherein the ionized sample S + " is filtered by ion species according to aspects of ion mobility.
  • a selected ionized species is outputted from the ion filter ("separator") and may be further processed in part D.
  • This further processing may include being detected to indicate presence of a biological material in the sample, and/or may include being collected and used as a biological material extracted from the sample.
  • the sample itself may be delivered aheady including ion species of interest.
  • region E receives the sample and transport fluid where they are mixed together in mixing region El in presence of an ionization source E2, or are mixed with an additional ionized fluid flow from source E2, all to provide the ionized sample S +/" that is delivered from region E to filter C.
  • Filter C is preferably a DMS filter.
  • an analyte is detected based on differences in mobility of the ionized analyte in a DMS electric filter field.
  • this field analysis includes high field asymmetric waveform ion mobility spectrometry-type differential ion mobility, as described in U.S. Pat. No. 6,495,823 or U.S. Pat. No. 6,512,224, and generally described herein as DMS.
  • These patents teach both gas transport of ion species and electric field ion transport of ion species, which may be practiced in embodiments of the present invention.
  • a DMS filter (separator) is tuned to pass a specific analyte of interest, and the passed analyte is then collected or processed accordingly.
  • the filter field is scanned through a range that enables detection and identification of a range of ion species that are present in the sample, including positive and negative species. This spectrum can be detected for a full characterization of the detected sample.
  • FIG. 2A A further practice of the invention is shown in FIG. 2A wherein system 10 includes separation sections "S-A" and "S-B” followed by identification section "ID".
  • a complex sample S* can be separated in first section S-A and the separated sample flow S is then applied to the second section S-B for further separation processing.
  • the result of both separations and the related S-A and S-B data is correlated and enables reliable identification of separated components from the complex sample.
  • the output of section S-B is evaluated in the identification section ID.
  • a preferred process of the invention includes using DMS to generate separation data and at least one other processing step that yields its own separation data. This additional separation step may be before or after DMS filtering.
  • the combination of detection data leads to highly reliable identification of ion species present in a complex sample even at trace levels.
  • the first separation section S-A includes a gas chromatograph (GC) and the second section is a DMS filter.
  • GC gas chromatograph
  • the present invention is an apparatus and a method for detection and identification of analytes in a sample by aspects of ion- mobility based detection, h this embodiment, a portion of a sample is directed into a first separation device, thereby obtaining a first profile of a sample. A portion of a sample is also directed into a second separation device thereby obtaining a second profile of a sample. At least one of the first and the second separation devices is a DMS device.
  • a "profile" includes any data obtained by a separation device, such as, for example, any ion-mobility signature, such as DMS mobility, time of flight, mass spectra, chromatographic retention time and the like.
  • the first and the second profiles obtained above are combined, thereby allowing identification of at least one analyte in a sample.
  • the combination of profiles can be done by way of comparison of the two profiles, whereby the presence of a particular analyte can be confirmed.
  • the combination can further include adding the data obtained by a first separation device to the data obtained by the second separation device.
  • the DMS practice of the invention may include a DMS filter in either or both separators S-A or S-B.
  • a preferred DMS system is shown in FIG. 2B, including a sample input section 10A, a DMS ion filter section 10B.
  • the DMS output is evaluated in the detection and identification section 10C in FIG. 2B (which constitutes the identification section ID of Figure 2A), wliich includes an intelligent controller/driver provided by command and control unit 34.
  • a memory or data store 33 is used to record separation or mobility signatures for known ion species and the apparatus is enabled with this data.
  • the DMS detection data can be correlated with the field conditions data (e.g., RF characteristics, compensation, flow rate, temp., etc.) and forms a detection dataset for the detected ion.
  • the detection dataset is compared to a signature dataset(s) for known ion species as stored in the data store. A match enables identification of the species of the detected ion.
  • the data store includes associated characteristic retention time data and data that relates to use of other separation techniques (such as a thermally controlled SPME prefilter).
  • the detection is both qualitative and quantitative. For example, upon detection of an ion associated with an anthrax molecule, a match with the stored data will enable identification of the detected species as "anthrax" and with an indication of detection level based on the intensity of detection. Such an indication may be issued as a warning to a display or other output device.
  • the DMS RF signal is generated and the compensation bias is applied to filter electrodes 20, 22 by drive circuits 32 within command and control unit 34.
  • a detector 26 is provided, and preferably a charge detector (e.g., Faraday type detector), including detector electrodes 28, 30. As ions contact the detector electrodes they deposit their charges and these detection signals are then amplified by amplifiers 36, 38, all under direction and control of unit 34.
  • a computer or microprocessor 40 correlates drive signals applied to the filter electrodes with detection signals from amplifiers 36, 38, and makes a comparison to stored data in data store 41, and then issues identification data 42 to a readout device, such as for indication of detection of the target molecule.
  • a GC output of section S-A delivers sample S as an eluant that is carried by a drift or carrier gas G into flow channel 11 at inlet 12.
  • the sample S flows toward a sample outlet 13 at the other end of flow channel 11.
  • Sample S may include various molecules including trace level analyte T.
  • the sample may be delivered directly from the GC (or in other embodiments may be delivered via a nebulizer, spray head, etc.), and flows into ionization region 14. Molecules in the sample are then ionized by ionization source 16.
  • the result of ionization is ionized analyte ions T+/- and other ions S+, S- with some neutral molecules S°, as may be derived from various chemical species that are in sample S. These ions may appear as monomers, dimers, clusters, etc.
  • the ions and neutral molecules is flowed into the ion filter section 10B for analysis.
  • the carrier gas carries the ionized sample into the analytical gap 19 formed between electrodes 20, 22 of filter 24.
  • filtering proceeds based upon differences in ion mobility in an asymmetric RF filter field alternating between high and low field values.
  • This filtering reflects unique mobility characteristics of the ions as species; the process enables discrimination of species based upon mobility characteristics in the field which reflects ion size, shape, mass, charge, etc.
  • an asymmetric field voltage, Vrf, applied across the filter electrodes 20, 22 generates a field F (e.g., 10,000 V/cm) whose strength alternates between high value Vmax and low value Vmin.
  • This variation in the field strength causes the ions to move transverse to the sample flow in the flow channel, with the transvers motion being representative of the characteristic field mobility of the ions.
  • the mobility in the high field condition differs from that of the low field condition, and this mobility difference produces a net transverse displacement of the ions as they travel longitudinally through the filter field between the electrodes, resulting in an ion trajectory over time. This trajectory will drive the ions into the filter electrodes, causing them to be neutralized, lacking a countervailing compensation.
  • a compensation such as a DC compensation voltage Vcomp, is applied to the filter to differentially compensate this transverse motion.
  • the compensation will compensate the transverse motion of a selected ion species and will cause it to return to the center of the flow path based on its compensated mobility characteristics. Thus this returned ion species is able to exit the filter without colliding with the filter electrodes and without being neutralized.
  • a compound may be represented by either or both positive and negative ions
  • modes such as T+ and T-, as such modes may be generated by ionization of the analyte molecules T.
  • both positive and negative modes of an ionized species can be simultaneously detected in detection and identification section IOC.
  • detector 26 includes biased detector electrodes 28, 30 that are capable of simultaneous detection of modes simultaneously passed by the DMS filter.
  • the in-line configuration of the flow path enables both modes of a species generated during ionization to flow into the DMS filter 24.
  • the DMS filter passes these modes during a mobility scan, where each is the passed species when the scanned field conditions are appropriate.
  • analyte T may produce ions T+ and T- which each will pass through the filter at the appropriate signature field conditions.
  • ion species are filtered based on mobility differences. Therefore in a preferred practice of the invention, all ions of an ion species will be passed on for detection, whether positive or negative ions, and which may be detected simultaneously. Accordingly the detector electrodes are biased so that one attracts the positive and the other attracts the negative ions.
  • both "positive mode” and “negative mode” ions of a species are detected simultaneously. Having both modes from a single detection provides a more unique signature for the detected ion species and therefore increases the potential accuracy of species identification of the invention. The benefit of mode detections is further discussed below.
  • the ions flow to the detector wherein electrode 28 may be biased positive and electrode 30 biased negative, and therefore electrode 28 steers the positive ions T+ toward electrode 30, and results in ions T+ depositing their charges on electrode 30.
  • electrode 30 acts as a steering electrode and steers the negative ions T- toward electrode 28, and results in ions T- depositing their charges on electrode 28.
  • both + and - ion modes may be detected simultaneously.
  • Single mode or dual mode detection data is combined with filter field parameter data and is then compared to stored data to make an identification of the detected analyte T, and this is combined with the separation data representing the first separation to enable highly reliable identification of the analyte of interest, even at trace levels.
  • discrimination of ions from each other according to mobility differences is achieved wherein the RF field and the selected compensation enables a particular ion species to pass though the filter.
  • a plot of detection intensity versus compensation for a given field strength is shown in FIG. 2C, where peaks Ta, Tb indicate intensity of the detection signal at compensation levels a, b for the particular RF field.
  • Peak “Ta+” represents the “analyte Ta” positive mode
  • peak “Tb+” represents “analyte Tb” positive mode
  • Pealc "Tb-” represents “analyte Tb” negative mode.
  • the intensity of the peak may be correlated with detection quantity.
  • the retention time associated with these peaks can be correlated with the peaks to improve reliability of species identification.
  • a first separator S-A e.g., a fast GC
  • a second separator S-B e.g., DMS filter
  • a pre-filtering step is provided by a front-end collector system S-C (shown in dotted outline) to enable a highly reliable, selective and sensitive advanced chemical detector system.
  • various analytes that are difficult to discriminate and detect can be identified with confidence.
  • the sample can be collected, such as by means of solid-phase micro-extraction (SPME) media, in pre-collector part S-C, and then delivered to a GC, in separator S-A, for further separation and followed by DMS separation in part S-B and species identification in part ID, according to the invention.
  • SPME uses a fiber or tube having coating material which preferentially adsorbs analytes from a sample matrix and delivers the analyte for further processing.
  • SPME is routinely applied to gas-phase liquid-phase extractions, such as for extracting organic analytes from a sample and delivering same for chromatographic analysis.
  • the preferred embodiment enables delivery of a volatilized or volatilizable sample which can be processed in gas phase.
  • Embodiments of the present invention enable provision of intelligent monitors for a variety of application. For example, smart air monitors, smoke detectors and the like can be provides. Programmable control of the separation sections or selection of dedicated components enables tailoring a system to particular needs.
  • An illustrative embodiment of this invention enables an advanced environmental detector of reasonably high analytical performance.
  • a SPME collector system 100 shown in FIG. 3, which provides a pre- filter front-end (see separation section S-C) and delivers sample S to the GC (separation section S-B) and then the DMS section S-B proceeds as described.
  • the SPME collector system 100 preferably has several SPME collectors 101, 102, 103 ... n. which are selected for special characteristics. For example, all may be designed to selectively deliver a particular type of analyte or a range of analytes into collector 110.
  • the SPME fibers introduce the sample S into collector 110.
  • a drift gas 112 is introduced into collector 110 and carries the sample S introduced by the SPME fibers to the separator S-A (e.g., GC). Now further separation, filtering, detection and identification proceeds as earlier described.
  • This SPME sampling may include the step of heating the SPME fibers to purge VOCs, or to pyrolyze/volatilize a sample that then is delivered into collector 110 and then for further processing such as by GC-DMS.
  • the heating may be provided by heaters 116 associated with the SPME absorber fibers 101, 103, 105, etc.
  • the system is controlled by controller 34.
  • the heaters may be switched on and off and in this manner can control sample delivery within a desired range of chemical compounds according to the characteristics of the switched SPME fibers. For example, upon detection signal, one or a series of the fibers 101-n can be heated to change the sample absorption profile and delivery characteristics. Heaters 116 can also be used to heat the fibers for purging of same or even for pyrolysis of the samples. Such heating can be ramped to create a desired profile.
  • the present invention provides detection of smoke and intelligent discrimination of components in the smoke.
  • the chemical composition of smoke from sources of interest exhibit measurable chemical differences that can be analyzed by the SPME-GC-DMS system.
  • a remarkable level of reproducibility for complex chemical process i.e., combustion of natural materials was obtained using simple sampling methods, hi a further embodiment, monitoring changing vapor composition with time of burn and detailed identification of volatile products from combustion is used in an augmented method of the invention.
  • the present invention is not limited to detection/discrimination of smoke. More broadly, the present invention enables analysis of compounds by including differential ion mobility analysis in compensated high field asymmetric waveform ion mobility RF fields in a compact package that can be manufactured using high volume techniques that result in low per costs and yet produces results comparable to expensive analytical equipment. Systems according to the invention can be light-weight and yet provide the ability to provide highly effective analytical equipment whether in the field or in the laboratory.
  • Devices of the invention are able to rapidly produce accurate, real-time or near real-time, in-situ, orthogonal data for identification of a wide range of chemical compounds.
  • Devices of the invention such as devices according to FIG. 2A through 2C and FIG. 3, enable distributed installation of detection systems such as can serve heating and air conditioning systems (HVAC), where air quality monitoring and/or flow control and mixing of interior and outside air is of interest.
  • HVAC system can be controlled by a central controller (e.g., controller 34), to meet user needs automatically or on demand.
  • DMS devices of the invention may incorporate various electrode configurations, including coaxially or non-coaxially cylindrical, curved, curvilinear, arcuate, radial, plate, parallel, planar or flat.
  • DMS devices may be focusing or non-focusing as practiced in DMS devices.
  • a preferred practice of the present invention is generally referred to as "plate-type", and it will be understood embodiments may use facing electrode portions, segments, sections, or plates, hi one embodiment, non-uniform focusing fields are generated between the DMS filter electrodes; such embodiment may include a curved flow path including flat, non-flat or curved DMS electrodes.
  • FIG. 4A and FIG. 4B alternative embodiments of electrodes 20 and 22 are shown.
  • filter electrodes labeled 20' and 22'
  • either one or both electrodes, labeled 20' ' and/or 22" can be curved or curvilinear.
  • segments 20A can be curved, thereby producing a focusing effect known in the art, or straight, thereby producing a field substantially similar to that produced by the electrodes 20 and 22 as shown in FIG. 2B.
  • their length can be variable.
  • the present invention is an apparatus for detection and identification of analytes in a volatilized sample using the mobility-based signature obtained by a differential ion mobility spectrometry (DMS) device.
  • DMS differential ion mobility spectrometry
  • system 100 includes a sampler or other particle collector 102 which delivers liquid or solid sample to apyrolyzer 104 (such as a commercially available pyrolyzer from CDS Analytical) which has an output coupled to the flow path 106 of the DMS analyzer 110.
  • apyrolyzer 104 such as a commercially available pyrolyzer from CDS Analytical
  • the flow path structure (sometime referred to as a drift tube) has an inlet 112 for receipt of the pyrolyzed sample output from the pyrolyzer carried by carrier gas 114.
  • the pyrolysate in transferred from the pyrolyzer to the DMS through a sealed and heated interface.
  • the pyrolysis chamber is purged while a stream of clean N2 is diverted into the DMS.
  • the flows are diverted through a valve into the analyzer to assist introduction of the pyrolate.
  • the pyrolyzer heated samples from room temperature to 1400 C at rates from 10 - 20 °C /msec.
  • the controlled temperature ramping enables selective desorption of compounds from the probe, therefore enhancing resolution and signal-to-noise of the apparatus.
  • a drying function evaporates and vents the solvent out a purge vent resulting in sample concentration and prevention of the solvent from entering the DMS analyzer 110.
  • a probe cleaning function flash-heats and desorbs left-over sample between analyses.
  • the pyrolate is carried by the carrier gas into the ionization chamber 120 where source 122 ionizes the sample.
  • the ions ("+", "-" are carried by the carrier gas into the filter 124 between filter electrodes 126, 128.
  • an asymmetric high-low varying RF field is generated between the filter electrodes, with applied DC compensation, under control of controller/driver 130.
  • Ion species are passed to the detector 132 based on compensated field conditions and mobility difference for the species. As the compensation is scanned, a spectrum can be recorded for the sample.
  • Detector 132 includes electrodes 134, 136, which enable detection of positive and negative modes for each species.
  • electrodes 124, 134 are formed on a substrate 140 and face electrodes 126, 136 formed on substrate 142.
  • the substrates are insulating.
  • the subsfrates are mated to fix the distance between the electrodes and defining the analytical gap G between the electrodes (preferably ⁇ 0.5mm). The asymmetric field is generated between these electrodes transverse to the analytical gap and the ions are flowed in the gap through the field.
  • a dual channel system 300 includes a first flow path 11 and a second flow path 311. As the ions are separated by passing through filter 24 in flow path 11, they are deflected by deflector electrode 320 into a detector 326.
  • the deflector electrode 320 is disposed substantially at the output of a flow path (here, a first flow path 11) of a differential mobility spectrometry (DMS) device.
  • the detector may include a detector electrode 327 which also can be biased to act as an attractor electrode 327 in combination with the deflector 320.
  • detections are made and then the identification process typically involves comparison against a lookup table of stored detection data.
  • a practice of the invention not only results in detection of a marker but also results in indication of the analyte with which the marker is associated. For example, if bacterial spores were in a sample, the above detection results would be obtained and would be compared against a store of related detection data. Upon a positive match, an identification announcement would be made.
  • the apparatus of the invention includes an on-board volatilizer portion and DMS analyzer, wherein collected samples are volatilized and then resulting gas sample is automatically transported to the analyzer and then detected for evaluation of presence of analytes in the sample based on ion mobility signatures
  • the volatilizer and DMS device may be made in a single package.
  • the sample collector may also be on-board.
  • a sample is identified by a multi-stage analysis, wherein a first stage filters a sample by particle size and defines a narrowed sample set, and in a second stage this sample is pyrolyzed and then analyzed based on high field ion mobility as discussed. Results of the first and second stage are correlated with known standards to identify the compounds in the sample.
  • An illustrative device comprises a housing defining at least one flow path between a sample inlet and an outlet, a plurality of ion filters disposed within the housing, each ion filter including a pair spaced filter electrodes, and an electrical controller for applying a bias voltage and an asymmetric periodic voltage across each pair of ion filter electrodes for controlling the path of ions through each filter.
  • the device provides an array of filters, each filter associated with a different bias voltage, the filter may be used to detect multiple selected ions without sweeping the bias voltage or, in an alternative embodiment, by simultaneously and independently sweeping the bias voltage in different ranges and at different fields. Filters may be in parallel or in series with one chemical sample processing through multiple ion filters.
  • EXAMPLE 1 E DOSPORE BIOMARKER 2,6- PYRIDINE-DICARBOXYLIC ACID (DIPICOLINIC ACID) IS DETECTED BY A DMS DEVICE AND BACILLUS SPORE BIOMARKERS ARE DETECTED BY A DMS DEVICE AFTER PYROLYSIS.
  • DP A 2,6- ⁇ yridine-dicarboxylic acid
  • the commercially available pyrolyzer PyroProbelOOO was acquired from CDS Analytical with the necessary functions to handle the introduction of liquid and solid samples into the DMS detector.
  • the pyrolyzer is capable of heating samples from room temperature to 1400°C at rates from 1 to 20°C/s.
  • the controlled temperature ramping enables selective desorption of compounds from the probe, therefore enhancing resolution and signal-to-noise of the DMS.
  • a drying function evaporates and vents the solvent out a purge vent resulting in sample concentration and prevention of the solvent from entering the DMS filter.
  • the pyrolate is transferred to the DMS through a sealed and heated interface.
  • the pyrolysis chamber is purged while a stream of clean N is diverted into the DMS.
  • the flows are diverted through a 6- ⁇ ort valve into the DMS for introduction of the pyrolate into the DMS.
  • a B. subtilis sample was analyzed using pyrolysis-ion trap mass spectrometry.
  • the concentration of the B. subtilis sample was 10' organisms/ml.
  • This experiment showed that the expected biomarkers and both DPA and picolinic acid (PA) were evident in the endospore spectra.
  • Other unidentified biomarkers were also measured using this technique as shown in the background spectral peaks.
  • FIGs. 8 dual mode
  • 9 dual mode
  • 10 single mode
  • FIGs. 8 dual mode
  • Picolinic acid was pyrolyzed through a temperature excursion of 130 to 300°C at a rate of 20,000°C/s, the interface temperature was held at 130°C.
  • Dipicolinic acid was pyrolyzed from 145 to 400 °C at 20,000 °C/s, the interface temperature was held at 145 °C.
  • Both PA (100 ppm) and DPA (100 ppm) produce positive and negative ion peaks that can be used for identification, h addition, pure DPA produces a secondary positive ion peak, further differentiating its fingerprint pattern.
  • the peak width at half height averages 1.4 V.
  • pyrolysis is capable of fully decarboxylating DP A to pyridine. Ideally, controlled and more gradual' pyrolysis conditions will lead to loss of only one carboxylic acid group to generate PA, enabling specific identification of the DPA source as bacterial spores. Due to the volatility of pyridine, pyrolysis was not necessary for introduction, and the interface temperature was held at 130°C. As seen in the DMS spectra, pyridine does not produce negative ions. The absence of a negative ion peak enables one to conclude that the pyrolysis conditions employed are mild enough to prevent full decarboxylation and that pyridine can be differentially detected.
  • FIG. 11A shows the full DMS spectrum of pyrolyzed B. subtilis spores as a simulant for B. anthracis.
  • the spores were suspended in dH2O at a concentration of 2.4 x 109 spores/ml.
  • the spores were diluted to 100,000 spores in 1 ⁇ l, and the sample was dried and pyrolyzed through a temperature excursion from 250°C to 400°C at 20,000°C/sec with the interface temperature at 250°C.
  • FIG. 11 A shows the time course of the DMS spectra after pyrolysis is initiated. The signal is complex and changes over time, indicating a large number of potential biomarker targets.
  • FIG. 1 IB shows a time course of both the positive and negative DMS spectra at 10 seconds after the onset of pyrolysis. Both spectra show biomarkers are detected. These results show the DMS is capable of detection of known endospore biomarkers.
  • Chemical changes in the living system or degradation processes of cells after death are accompanied by the formation of molecular byproducts. These processes include the breaking down of peptides and DNA strands to smaller components, and changes in amino acids that lead to the formation of amines.
  • One of the processes of particular interest is the breakdown of amino acids and the production of diamines and polyamines.
  • An atmospheric pressure ionization method of the invention is particularly suited for the detection of these markers, such as biogenic amines, since they tend to have either high proton affinity and form stable positive ions or high electro-negativity and readily form negative ions that are detected in a DMS system of the invention.
  • FIG. 12 shows DMS spectra detected according to a food-quality embodiment of the invention for a mixture containing both putrescine and cadaverine.
  • the putrescine peak at about -30 volt compensation is well separated from the cadaverine peak at -29 volts, and which are separate from the detected n- Nonylamine. Based on these results, it will be appreciated that a food-quality detector of the invention can be used to evaluate the quality of a food sample, such as meat, based on the detected presence and intensity of these bio-markers.
  • Another application of the invention is in breath analysis.
  • the human breath contains over 400 organic compounds at concentrations typically in the parts-per- million (ppm) to parts-per-billion (ppb) range.
  • ppm parts-per- million
  • ppb parts-per-billion
  • the concentration of these compounds in the breath can be correlated to their concentration in the blood, as noted through the widespread use and acceptance of a breath analyzer to determine alcohol consumption.
  • a non-invasive DMS breath analysis system is provided, hi one set of experiments, sample collection involved collecting a breath sample directly onto a solid phase micro-extraction (SPME) fiber assembly. The SPME fiber was placed in proximity to the mouth of the subject and the sample collected for two minutes.
  • SPME solid phase micro-extraction
  • the SPME assembly was coupled to a GC injector port which was held at 120C and desorbed the sample from the fiber into the GC column.
  • the present wide-spectrum DMS was attached at the detector port of the GC for DMS filtering and species identification of the GC elute.
  • FIG. 13 A background baseline spectra without sample on the SPME fiber is shown in FIG. 13. Spectra from subject #1, FIG. 14, and subject #2, FIG. 15, are very similar except for the peak at a compensation of about -3 volts for specimen #2. Using the GC alone, without the benefit of the present invention, the presence of these different compounds would not be evident.
  • the resultant GC-DMS plots shows the chromatographic retention time on the y-axis and the compensation voltage plotted on the x-axis and shows the value of the detector in providing additional information to simplify and assist in the analysis of a human breath sample, as a viable practice of the present invention.
  • DMS direct sampling and analysis by DMS can be practiced without SPME.
  • spectra for markers from pyrolyzed B. subtilis were identified.
  • Spectral DMS scans for pyrolyzed water sample are shown in A
  • 40,000 spores pyrolyzed are shown in B
  • 120,000 spores pyrolyzed are shown in C.
  • markers at 1, 3 and 4 correlate with the presence of spores, with amplitude corresponding to concentration.
  • a lookup function of a device of the present invention enables identification of ion species detected in urine.
  • This experiment is illustrative of establishing baseline upon which a specific detector can be established. For example, detection of such analytes as pronase, (NH 4 ) 2 SO 4 , KH 2 PO 4 -H O, CK2O3, K 2 CO 3 or NaCl can be detected.
  • a DMS device suitable for practice of the present invention was interfaced to a GC and used as a chromatographic detector. The system performance was compared with the Flame Ionization Detector (FID). The average FID detection limit was 2E-10g, while a preferred DMS system of the invention had a detection limit of 2E-llg. Furthermore, the DMS is flame-free. Similarly to a mass spectrometer, the ion information provided by the invention offers a second dimension of information to a GC chromatogram and the ability to enhance compound identification. FIG.
  • FIG. 18 shows spectra according to a GC-DMS embodiment of the invention, with the part shown as a chromatogram (right frame) being typical of what is seen from a FID.
  • the chromatogram is the sum of the peak intensities for the product ions created.
  • the associated two-dimensional plot (left frame) of ion intensity (indicated by gradient) versus scanned compensation voltage provides a means of fingerprinting the compounds eluted from the GC. Therefore practice of the invention provides three levels of information: retention time, compensation voltage, and ion intensity, all shown on the spectra of FIG. 18.
  • a preferred in-line DMS system of the invention such as taught in US Patent No.
  • spectra may be obtained simultaneously for positive and negative ions, i.e., dual mode, augmenting or eliminating the need of serial analysis under possibly changing instrumental conditions, as required with other equipment.
  • decreased GC runtime produced co-eluting species that were subsequently resolved in the DMS spectra.
  • a fast GC can be used while maintaining the required compound resolution.
  • the reproducibility of the present invention compares very well to that of the FID as shown in FIG. 20.
  • FIG. 20 shows a comparison of FID and DMS reproducibility for a homologous alcohol mixture.
  • Pressure on the injector ports was nominally 5 psig with a split ratio of 50:1 and was adjusted individually so retention times between instruments matched. Split flow was -30 mL/min and septum purge was 3 mL/min. Bottled nitrogen (99.99%) was used as carrier gas for the GC/FID and GC/DMS. Helium (99.99%) was scrubbed over a Hydrox Purifier Model 8301 catalytic reactor (Matheson Gas Products, Montgomeryville, PA, USA) and used as carrier gas for the GC/MS. Parameters for the FID with integrating recorder were: threshold, 3; area reject, 100; and attenuation, 2. Parameters for the MS were: mass range, 50 to 550 amu; threshold, 500; scan rate, 1.5 scans/s; and electron multiplier voltage, 1600 V according to the automated calibration routine.
  • the differential mobility spectrometer contained a planar micro-scale drift tube made from ceramic plates with gold plate copper base electrodes.
  • the separating electrodes were 4 mm wide x 6 mm long and a width of 0.52 mm was used for the gap between the electrodes.
  • Electrodes were fixed in a metal body to which a -1 Ci Ni ion source was attached. The ion source was connected to a transfer line into the GC oven. Air at 0.5 L/min was heated and passed into the transfer line for gas flow through the DMS analyzer. The transfer line and DMS analyzer were maintained at the same temperature. Air was provided using a pure air generator (Mode 737, Addeo Corp, Miami, FL) and was further purified through beds of 13x molecular sieve.
  • Moisture in the carrier gas was monitored using a model MIS-2 meter (Panametrics, hie, Waltham, MA) and was 30 ppm or below.
  • the drift tube was operated using in-house built electronics containing an RF wavefonn generator, a sweeping voltage generator, and an electrometer.
  • the waveform generator was based on a soft-switched, semi-resonant circuit that incorporated a fly-back transformer and allowed variable peak-to-peak amplitudes of the asymmetric waveform from 200 V to 1600 V without altering the waveform shape.
  • the operating frequency of the RF generator was 1.3 MHz.
  • a compensation voltage ramp was synchronized with the data collection syste and provided a scan of compensation voltage from -10 V (or -5 V) to +30 V (or 24 V) at a frequency of 1 scan every 3.8 (or 2.8) s.
  • Signals were processed using a model 6024E National Instruments (Austin, TX) board; spectra were digitized and stored for every scan using software derived from Lab view (National Instruments).
  • the pyrolysis apparatus was model 150 Pyroprobe (CDS, Inc., Avondale, PA) pyrolyzer with a platinum ribbon probe.
  • the probe was housed during analysis in a glass chamber, with a gas flow inlet and needled outlet. Dimensions of the glass chamber were: inner diameter, 7.2 mm; outer diameter, 9.2 mm; and length, 15 cm.
  • the chamber was attached to the pyrolyzer through a 3/4" tube union (Swagelock Company, Solon, OH) and the needle attached to the end of glass chamber via 1/4- 1/16" Swagelok reducing unit.
  • the total volume of the chamber exclusive of the probe was 3.6 mL.
  • Nitrogen was provided to the chamber at 44 mL/min during the run, so the gas volume of the chamber was replaced every 5 s.
  • the chamber was wrapped with a resistive wire heater and insulated with glass pack to maintain temperature at 250 °C during transfer of the pyrolysate to the GC injection port.
  • Escherichia coli K-12 (strain # 25), Micrococcus luteus (strain # 52) and Bacillus megaterium (strain # 61) were obtained from the New Mexico State University Culture Collection. The three cultures were grown for 17 hrs in nutrient broth (Difco, Detroit, MI) in an orbital shaker (150 RPM) maintained at 30 °C. The cultures were harvested by centrifugation (10,000 RPM, 2 min.), re-suspended in sterile water, spun again, and then re-suspended in sterile water. The cells were quantified by sequentially diluting the cells and plating sub-samples onto nutrient agar plates, and counting resultant duplicate samples.
  • B. megaterium cells Under these growth conditions, 66 % of the B. megaterium cells had sporalated as measured by staining with Brilliant Green and microscopic examination. The cells were pyrolyzed and analyzed on the day of preparation, or were stored at 4 °C and analyzed within one week. Biomarkers included Lipid A (CalbiochemNovabiochem Co., La Jolla, CA) ; Lipoteichoic Acid (from BIOTREND Chemikalien Germany); and dipicolinic acid (Aldrich Chemical Co, St. Louis, MO) and were used as received without further treatment.
  • Lipid A CalbiochemNovabiochem Co., La Jolla, CA
  • Lipoteichoic Acid from BIOTREND Chemikalien Germany
  • dipicolinic acid Aldrich Chemical Co, St. Louis, MO
  • the pyroprobe containing the Pt ribbon was heated to 800-900 °C or inserted into the flame of a Bunsen burner to remove residues of previous measurements. Sample volumes of approximately 20 L were applied by micropipette onto the surface of the Pt ribbon and dried at -75 °C in air for 1 to 1.5 minutes. The temperature of the glass chamber of the pyroprobe was 250 °C. 10 ⁇ L of bacterial sample was placed on the pyroprobe ribbon. Directly before the GC analysis, the pyrolysis apparatus with the pyroprobe containing bacteria was purged with nitrogen at a gas flow of -44 mL/min for -6 s (one replacement volume of the pyrolysis chamber).
  • Results from the pyrolysis of three bacteria with GC/DMS analysis are shown as plots of ion intensity, retention time, and compensation voltage in FIG. 21 and FIG. 22.
  • plots for positive ions are shown from the pyrolysis of E. coli, M. luteus, and B. megaterium in frame A, B, and C, respectively. Constituents were seen above background throughout a column temperature range from 50 to -
  • the more offset peaks (such as at higher values of compensation voltage) will be of lower molecular weight than those at 0 V and are consistent with molecular masses of -50 to -120 amu. Peaks with compensation voltages of 0 to -3 V are found with ions off high mass which exhibit negative dependence of mobility on electric field strength (approximately 150 amu and higher). Thus, the compensation voltage axis can be viewed as a measure of low (at 8 V) to high (at -3 V) mass spanning a range from approximately -50 to 250 amu. Each bacterium produced a pyrolysate with a complex mixture of volatile compounds and this was observed in results from the GC/DMS, GC/FID and GC/MS. In FIG. 21, a general trend can be seen in the plots for increases in molecular weight with increases in retention time. However, some differential mobility spectra can be seen with two peaks at differing compensation voltages.
  • a protonated monomer will form a cluster with a sample neutral to form a proton bound dimer, M2H+(H2O) n , when sample vapor concentration is increased.
  • the proton-bound dimer will appear at the same retention time as the protonated monomer though compensation voltage will be displaced in the direction of zero that for the protonated monomer.
  • This can be an additional component in the orthogonal differential mobility spectrum as a measure of concentration or abundance. An example of this is evident in FIG. 21 C with a component at a retention time of 6 min. where two peaks are seen at 3.4 V and -1 V in the differential mobility spectrum.
  • Ionization chemistry with negative ions is generally more selective than that for positive ions and based upon O2 " (H 2 0) n attachment to a neutral. This occurs with molecules containing acidic protons or electronegative groups, hi some instances, the product or adduct ion (MO 2 " (H 2 0) n-1 ) may dissociate to form M " or M-H " .
  • the plots of retention time versus compensation voltage for negative ions also showed a large number of constituents between 0 to 20 min elution times and compensation voltages from 10 to 0 V. However, fewer constituents were observed for negative ions versus that for positive ions with from 31 to 39 peaks detected and resolved.
  • Crotonic acid was noticeable in the negative ion py-GC/DMS plots and was expected since carboxylic acids exhibit favorable ionization chemistry with O 2 " (H 2 0) n .
  • results in FIG. 21 and FIG. 22 were compared favorably to results by py-GC/FID and py-GC/MS with the same sample.
  • the results in FIG. 21 and FIG. 22 demonstrate that a DMS analyzer shows response with detail for molecules spanning a range of molecular weights from 50 to 250 amu (gauged from retention time or temperature) and that the existing DMS analyzer provided resolution of chemical information orthogonal to retention.
  • Biopolymers for some major constituents in bacteria are available as purified substances though the choice of materials is limited by genus and species.
  • Lipid A and lipoteichoic acid were obtained commercially and were characterized by py- GC/DMS in order to compare these prospective sources of bacterial chemical information to actual results from bacteria samples.
  • the findings show that some of the peaks from E.
  • coli can be matched to peaks from Lipid A using retention time and compensation voltage. However, peaks can be seen in the plot for E. coli which are not associated with and in plots from analysis of Lipid A and peaks can be seen from Lipid A that are not evident in E. coli.
  • the positive control with a mixture showed that differences were not due to matrix effects of any chromatographic uncertainties such as adsorption at active sites. Rather, the profiles were additive as shown in FIG. 23C and the differences cannot be attributed to pyrolysis, GC separation, or ionization chemistry in DMS analysis. These differences are likely due to the origin and composition of Lipid A which came from Salmonella Minnesota and not from the genus Escherichia. Thus, the patterns seen in the plots for E.
  • coli may be understood to arise from pyrolysis ofbiopolymers other than Lipid A.
  • Results from py- GC/DMS analysis of M. luteus, lipoteichoic acid, and a mixture of M. luteus with lipoteichoic acid showed different patterns from those in FIG. 23, though the virtually identical conclusions as that with Lipid A. hi this instance, the lipoteichoic acid was isolated from Streptococcus pyrogenes. Consequently, associations between peaks in bacteria with pyrolysis products from biopolymers were unsuccessful. Instead, chemicals known as pyrolysis products from bacteria were obtained as authentic chemical standards and were used to evaluate results from py- GC/DMS and py-GC/MS.
  • Volatile and semi-volatile organic compounds are produced from the pyrolysis of bacteria and these have been recently described by Snyder et al. Samples of most of these chemicals were obtained commercially as authentic standards and were characterized for retention time (t r ) and compensation voltage (C v ) by GC/DMS, and for retention time and mass spectra by GC/MS. All chemicals except some carboxylic acids exhibited distinct chromatographic retention, distinctive compensation voltages, and mass spectra which matched reference spectra (exceptions included carboxylic acids which, apart from a few exceptions, were either adsorbed on active sites in the injector port or showed poor chromatographic efficiency on the non-polar stationary phase). The location of these chemical standards in plots of retention time versus compensation voltage are shown in FIG.
  • crotonic acid has not been used previously as a biomarker for spores and is regarded as a chemical for Gram-positive bacteria in general, crotonic acid was not seen above detectable levels in analyses by py-GC/MS or py-GC/DMS of M. luteus. Rather, B. megaterium with high spore content only produced crotonic acid here.
  • spores were distinguished by the presence of picolinic acid and pyridine or methyl derivatives of picolinic acid.
  • picolinic acid was absorbed on active sites of the injection port when solutions of 10-100 ng/ ⁇ l were analyzed. Discrimination between Gram-negative and Gram-positive bacteria required detailed attention to plots in FIG. 24 and FIG. 25 and the identification of peaks unique to each bacterium type.
  • the separation voltage was varied to explore effect on resolution between peaks on the compensation voltage axis.
  • Results are shown in FIG. 26 from py-GC/DMS characterization of B. megaterium for positive ions from four settings of the separation voltage (low to high, bottom to top).
  • the reactant ion peak (Equation 1) is evident at compensation voltages from 3 V to 5 V with a center at 4 V. Throughout this analysis, this peak is visible and exhibits a small drift in compensation voltage. This is attributed to a small increase in temperature of the drift tube during the GC column temperature program caused by poor thermal control of the drift tube.
  • product ions appear throughout the chromatogram at compensation voltages between 2.5 to 0 V, a small band for distribution of analytical information.
  • voltage is increased from 688 V to 860 V (FIG. 26C)
  • the reactant ion peak is shifted from -4 V to -7.5 V consistent with a positive alpha function known for hydrated protons.
  • Product ions in positive polarity also show changes in compensation voltage as the separation field is increased and some ions have been shifted to compensation voltages higher than those in FIG. 26A. These are known to occur through changes in AK and are characteristic of ions with masses below 150-200 amu, namely protonated monomers of small molecules as marked in FIG. 26.
  • Detectors in gas chromatography are operated generally at temperatures 50 °C or higher above the maximum temperature applied to the column and these guidelines are intended to prevent sample condensation in the detector.
  • temperature has secondary effects in IMS analyzers including ion declustering, > dissociation, or decomposition.
  • a concern was the compromise between sample condensation in the detector and distortion of analytical information through changes in ion stability with temperature increases.
  • Results from py-GC/DMS screening of B. megaterium with four temperatures of the DMS drift tube are shown in FIG. 27; gas temperature was determined in the flow vented from the drift tube. The pattern of peaks at two or more compensation voltages seen at 55 °C (FIG.
  • Mobility spectrometers equipped with radioactive ionization sources such as 63 Ni exhibit proportional and quantitative response toward vapor concentrations for peak intensities in mobility spectra though linear ranges may be only 10-100. Differential mobility spectrometers show detection limits from 10-100 pg for volatile organic compounds and linear ranges of 100-1000. Response from py- GC/DMS analysis of bacteria is shown in FIG. 28 for integrated peak area versus number of bacteria applied to the pyrolysis probe. The plots were made using only the area for a single biomarker and the DMS was operated for maximum ion resolution (a large separation voltage). Consequently, the plots in FIG. 28 do not represent optimum conditions of temperature, separation field, or data processing to establish a limit of detection.
  • the detection limits will be governed by the DMS through the balance between resolution and ion yield, which are inversely related and controlled primarily by separation field. That is, increased resolution attained through increased separation field results in this generation of DMS with increased ion losses, hi limited studies to confirm these expectations, separation fields were decreased and 6000 bacteria were detected for E. coli using a single biomarker.
  • TOF-FMS time-of-flight ion mobility spectrometry
  • the TOF-IMS operates with low strength electric fields where the mobility of an ion is essentially constant with electric field strength, while the present invention operates in periodic high fields and filters based on the non-linear mobility dependence of ions on the high strength fields.
  • the invention can provide more and different structural information about ion species that further enables accurate species detection and identification. Further comparison with TOF- FMS is instructive.
  • mixed xylenes are the second-most-important aromatic product for chemical manufacturing around the world, ranking behind benzene and ahead of toluene.
  • p-xylene is the most widely used isomer in the manufacture of polymeric materials. Separation of these isomers is generally challenging with most analytical instruments. Since these isomers have the same molecular weight they cannot be resolved in a mass spectrometer.
  • FIGs. 31 and 32 show the response and concentration dependence in DMS practice of the invention for methyl salycilate, a chemical warfare agent simulant.
  • FIG. 31 shows positive ion spectra for different concentrations of methyl salycilate.
  • FIG. 32 shows concentration dependence of the system to methyl salycilate for both positive and negative ions. Samples with concentrations of methyl salycilate down to about 45 parts-per-trillion are readily detectable in this device.
  • the methyl salycilate compound produces both positively and negatively charged ions which exhibit similar concentration dependences.
  • the apparatus of the invention is able to simultaneously detect both ion responses within the same analytical run. Producing simultaneous positive and negative ion species information improves compound identification at reduced detection times.
  • Smoke from combustion of cotton, paper, grass, tobacco and gasoline were sampled by SPME and the samples were screened using a GC-DMS.
  • a measure of the chemical vapor composition of several materials using GC-MS was performed, as well as discrimination of vapor profiles between the tested analytes (including several cellulose materials) by GC- DMS, and then identification of chemical markers specific to the burning of a particular material.
  • model 5880 gas chromatograph (Hewlett-Packard Co., Avondale PA) was equipped with a HP splitless injector, 25 m SP 2300 capillary column (Supelco, Bellefonte, PA), a flame ionization detector, and a DMS detector.
  • a model 5880 gas chromatograph (GC) (Hewlett-Packard Co., Avondale PA) was equipped with a HP splitless injector, 25 m SP 2300 capillary column (Supelco, Bellefonte, PA), a flame ionization detector.
  • the carrier gas was nitrogen (99.99%) scrubbed over a molecular sieve bed and pressure on the splitless injector was 10 psig with a split ratio was 50: 1.
  • Other experimental parameters for the GC included: initial temperature, 30°C; initial time, 5 min; program rate 15°C min-1; final temperature, 200°C; final time, 1 min.
  • the DMS detector was equipped with -0.6-1 mCi of 63Ni.
  • the drift gas was air at 1 to 2 1 min-1 from a model 737 Addco Pure Air generator (Miami, FL).
  • the drift gas was further purified over a 5 A molecular sieve bed (10 cm diameter X 0.6 m long) and passed through heated stainless steel tubing to warm the drift tube to 70°C.
  • the analytical column was attached to the DMS drift tube through a 30 cm length of aluminum-clad column and column effluent was carried by drift gas through the ion source region for sample ionization.
  • the drift gas also carried product ions through the gap (0.5 mm) between two flat separating electrodes (5 x 25 mm).
  • Two electric fields were applied to the drift tube: a non symmetric waveform high frequency (1.3 MHz) with strong electric field (20 kV cm-1 peak to peak amplitude) and a weak DC field (-360 V cm-1 to +80 V cm-1) of compensation voltage (-18 to +4V).
  • Signal was processed using a National Instruments board (Model 6024E), digitized and stored.
  • the gas chromatograph-mass spectrometer was a model 5890 A gas chromatograph and Model 5971 A mass selective detector (Hewlett-Packard Co., Palo Alto, CA) and was equipped with a 25 m SP 2300 capillary column (Supelco, Bellefonte, PA).
  • the operating parameters of the gas chromatograph/mass spectrometer (GC/MS) were identical to those for GC-DMS listed above.
  • Supelco Bostodian, PA.
  • a mixture of hydrocarbons (hexane to hexadecane) was prepared in methlyene chloride solvent at 100 ng/ul per alkane.
  • the alkanes were obtained from various manufacturers and were used as a standard for calibration of chromatographic retention. Materials were all obtained locally and included paper as shredded newspaper; cotton; tobacco as cigarettes; and grass as dried Bermuda grass.
  • a wad of -9 cm3 of loosely held material (cigarette excepted) was placed in the end of a borosilicate glass tube (2.54 cm OD X 6 cm long) which was held level and a flame from a butane lighter was used to ignite the sample.
  • the apparatus was placed in a fume hood where flow of air created air flow through the tube and allowed a sustained but low level burn of the sample over 3-8 minutes. Hot vapor and particulate emissions from the sample were released in a plume from the sample and the SPME fiber was held in this plume simulating field sampling of ambient air.
  • the time of sampling was 4 s for cotton, 6 s for cigarettes, 8 s for paper and 10 s for grass.
  • Samples of engine exhaust from a forklift track were taken by holding the SPME fiber in the exhaust stream approximately 0.5 meter from the end of the tailpipe. The samples were freshly analyzed by GC-MS or GC-DMS. h an injection, the SPME was placed in the injection port under splitless mode and held for 30 seconds until the inlet was switched to split mode. The SPME fibers were conditioned between runs for 10 minutes at 220°C in nitrogen. Repeatability was obtained by four replicate measurements of cotton burns with 4s sampling of the smoke plumes. The al ane standard was used to calibrate retention on the GC-MS and the GC-DMS. Detection of VOCfrorn Combustion of Fuel Sources by GC-MS
  • Time (in minutes) for the alkanes were: decane, 4.27; undecane, 5.54; dodecane, 7.00; tridecane, 8.40; tetradecane, 9.81; pentadecane, 11.17; hexadecane, 12.47, and octradecane, 15.79 (alkanes with carbon numbers below 10 were lost in the solvent delay).
  • the traces in FIG. 33 spanning 2 to 20 minutes retention illustrate that all samples exhibited a complex mixture of VOCs from adsorbed aerosols (desorbed in the injection port) and molecular weights for these compounds can be estimated as -150 to 250 amu.
  • Ion mobility spectrometers are equipped with an atmospheric pressure chemical ionization (APCI) source and an intermediate step was to determine if the pre-separation could be eliminated from the method.
  • APCI atmospheric pressure chemical ionization
  • Direct sampling of emissions using an APCI mass spectrometer was made to determine the APCI response to effluent constituents and to measure the resolution possible with a mass spectrometer alone.
  • GC-DMS analysis of VOCfrom combustion of various materials While samples may be drawn directly from the ambient environment into the first separation stage S-A in embodiments of the invention, we now discuss GC- DMS analysis of SPME-collected samples of combustion emissions, as shown in FIGs. 35 and 36 as chromatograms of total intensity of product ions from the mobility scans in comparable format to total ion chromatograms from GC-MS (see FIG. 33). Plots are shown for cotton, paper grass, cigarette and gasoline engine smoke and the findings reflect the same level of complexity (i.e., number of resolved constituents) as seen above in the GC-MS plots.
  • the VOCs spanned the range of carbon numbers from 10 to 18 as shown in retention times spanning 3 to 15 minutes.
  • times (in minutes) were: nonane, 3.54; decane, 4.52; undecane, 5.81; dodecane, 7.24; tridecane, 8.77; tetradecane, 10.27; pentadecane, 11.78; and hexadecane, 13.43.
  • the run was ended before octadecane eluted; alkanes with carbon numbers below nine appeared in a large unresolved pealc from 2 to 3.5 minutes. Differences were observed in relative abundances of constituents within the chromatograms between FIG.
  • the peaks unique to cotton were labeled in FIGs. 33 and 35 and summaries of the mass spectral properties for these are shown in Table 1.
  • the GC-DMS results could be compared directly to the findings from GC-MS and certain peaks were found in the cotton to be unique or special to cotton combustion. These are labeled in FIG. 35 and mass spectral properties are listed in Table 2.
  • the 2D plots are particularly good for quantitative measures but do not disclose the analytical value of orthogonal information available in the mobility scan. This can be seen in the topographic plots of FIGs. 37 and 38.
  • FIGs. 39 and 40 plots of ion intensity at four compensation voltages (4.06V, -1.8V, -4.47V, and -10.35V) are shown top to bottom in each frame for cotton, paper, grass and gasoline engine exhaust.
  • This approach which is analogous to ion chromatograms in GC MS measurements, certain regions of compensation voltage were graphically extracted from the matrix of retention time, compensation voltage and ion intensity.
  • a measure of the amount of chemical information in the selected ion mobility plots from GC-DMS can be seen in these figures where differences in samples are further accentuated. These patterns are distinct and show that selected ion plots allow a route to chemical identification where information can be compressed through fast chromatography.
  • a further embodiment includes forming ratios of two or more extracted ion chromatograms.
  • the findings in FIGs. 39 and 40 demonstrate that adequate resolution of peaks is available in these complex patterns to compress the chromatographic time scale. At present the scan time of 1 s may be too slow for below 3 minutes. Since ion residence in the drift tube is 1-2 ms, ion hopping could occur for a set of ions in 40 ms, (4 ions for 10 ms each). Thus, high speed GC where the complete separation occurs in 60 seconds is preferred to allow high cycles (e.g., 1000) throughout the measurement. The time resolution of 1 part in 1500 would be comparable to the current value of 1 in 960.
  • the drift tube with ion hoping enables high speed GC-DMS as a realistic smoke detector to distinguish sources of smoke.
  • Table 1 Retention times and ions in mass spectra from peaks that appear distinctive to cotton emissions.
  • DMMP Dimethyl methylphosphonate
  • DIMP Diisopropylmethylphosphonate
  • MS Methyl Salicylate
  • Three independent vapor generator systems Vici Metronics hie, Model 190 were used to generate controlled air mixtures of the simulants at different concentrations.
  • the maximum sample concentrations that could be provided was 1.6 mg/m 3 for DMMP, 3.01 mg/m 3 for DIMP, and 52.4 mg/m 3 for MS.
  • the DMS filter was operated in one aspect where it sampled effectively 100% of an incoming trace gas sample.
  • the compensation voltage is fixed such that a particular ion species, identified by its differential mobility, is permitted to reach the detector.
  • This is in contrast to conventional IMS which typically uses a gate which is pulsed "open" for approximately 1% of a measurement cycle resulting in only about 1% of the ions being sampled.
  • the DMS filter of this embodiment did not contain an ion-gate as in IMS devices, and is therefore more sensitive than gated approaches (where large portions of the sample signal are discarded). In addition to the absence of a gate, in the present invention it is possible to improve sensitivity wherein the signal can be integrated over a relatively long period of time.
  • the DMS was also operated in a second aspect in order to produce a spectroscopic output by scanning a range of compensation voltages. This reduces the "effective" duty cycle, but since the range of compensation voltages that is scanned can be selected by the operator, the "effective" duty cycle for any type of ion species is significantly higher than in conventional IMS.
  • the sensitivity of the system is higher than conventional IMS with the ability to detect compounds in the ppt range. Increased sensitivity is invaluable, especially in applications requiring miosis level detection. However, a detector which has high sensitivity without selectivity leads to an even higher rate of unwanted false positives.
  • enhanced selectivity in the DMS systems of the invention are provided by changing the electric field strength applied to the ionized molecules.
  • Tunable resolution also enables the REP (reactant ion peak) to be displaced away from the peaks of interest.
  • the RIP is a background peak that frequently interferes with the detection of targeted compounds in conventional IMS. This property of the invention enables the detection of trace compounds in backgrounds that produce interfering signals, or in some situations where the RTF or other compounds would otherwise interfere with successful detection. Tracking how the spectral peak position shifts with RF field provides a great deal of information unique to that ion species, peaks for other ion species will shift very differently. These are species-specific signatures which can be used to identify detected species in practice of the invention.
  • embodiments of the present invention can simultaneously detect both positive and negative ion peaks, modes, which further helps to improve selectivity.
  • the absence or the presence of peaks, and their size and location, in the positive ion channel versus the negative channel provides more information on the specific compound identity.
  • the ratios between intensities of positive ions and negative ions for a given sample also provides additional information which enhances confidence of the detection.
  • FIG. 42A and FIG. 42B illustrate this for the nerve agent GA. These spectral plots were measured at a Vrf of l,482v which corresponds to a field strength of
  • the characteristic spectrum for the positive ions is very different from the negative ion spectrum.
  • An additional embodiment of the present invention addresses this concern by operating the system at slightly reduced pressures relative to atmosphere. Under these reduced pressure conditions, down to 0.5 atmospheres, the resolution according to the invention is significantly increased.
  • the effect of reduced pressure is illustrated in FIG. 43 for three CWA simulants, DMMP, DFMP, and MS.
  • the top scan discriminates between the three simulants with some spectral overlapping but which may be adequate in some cases. However the next lower scan has better resolution (narrower peaks) and the lowest scan has even better resolution.
  • a further advantage of reducing pressure in the system is that the amplitude of RF voltages required to filter the ions can be reduced, this results in a lower power requirements which is especially important for field-portable systems of the invention.
  • direct sampling of volatile chemical agents provides adequate detection results, as was the case with FIG. 41, especially in the upper scans.
  • a first stage of separation such as previously discussed which results in providing a less complex ionized sample to the DMS, resulting in a less complex sample being ionized and filtered in the DMS filter.
  • a membrane was used at the input of the
  • DMS filter system prior to ionization such as at separation stage S-A in FIG. 2A.
  • the plots of FIG. 43 were obtained with such a membrane front end. Selection of membrane is guided by the need to selectively pass CWA agent molecules while acting as a barrier to moisture and heavier molecules (whether dirt, dust, hydrocarbon exhausts or the like). Thus a better and more controlled analytical environment can be provided within a detection system of the invention with a less complex sample being ionized and filtered within the DMS filter.
  • the plots of FIG. 43 were taken using a membrane front end as separator that selectively introduced the detected CWA agents as indicated while acting as a barrier to moisture and unwanted heavier molecules.
  • Various membrane materials are known in the art, including partially porous materials. These materials may include Teflon, latex, pdms, dimethyl silicone, or the like, as may be used in membrane practices of the invention.
  • FIG. 44 demonstrates a practice of the invention for a series of warfare agent simulants selectively mixed with 1 % headspace of AFFF. As can be seen, good DMS peak resolution can be achieved in practice of the invention.
  • the top plot shows the RIP for a DMS system with background air but no sample present with the sensor at atmospheric pressure. The next plot shows AFFF interferant added.
  • the present invention enables method and apparatus for high field asymmetric waveform ion mobility spectrometry, which can be favorably augmented with other collection and separation techniques, and packaged in a compact system.
  • Other than planar configurations are possible.
  • DMS configurations which may be practiced according to the invention may include method and apparatus using co-axial, cylindrical, flat, planar, radial, curved and other DMS electrode configurations.
  • Embodiments of the invention may even be practiced augmented with prior art IMS and DMS filtering.
  • a simplified hand-held device of the invention is dedicated to detection of a limited set of data and yet reliably detects and identifies ion species of interest.
  • This practice may be augmented by dual mode detections. The result is added reliability in chemical detection in a simplified device.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Sampling And Sample Adjustment (AREA)
EP04719211A 2003-03-10 2004-03-10 Systeme zur differential-ionenmobilitätsanalyse Withdrawn EP1601948A2 (de)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US45328703P 2003-03-10 2003-03-10
US45344803P 2003-03-10 2003-03-10
US45345103P 2003-03-10 2003-03-10
US453451P 2003-03-10
US453448P 2003-03-10
US453287P 2003-03-10
US46830603P 2003-05-06 2003-05-06
US468306P 2003-05-06
US10/462,206 US7005632B2 (en) 2002-04-12 2003-06-13 Method and apparatus for control of mobility-based ion species identification
US462206 2003-06-13
US69770803A 2003-10-30 2003-10-30
US697708 2003-10-30
US53081503P 2003-12-18 2003-12-18
US530815P 2003-12-18
US54900404P 2004-03-01 2004-03-01
US549004P 2004-03-01
US79477604A 2004-03-05 2004-03-05
US794776 2004-03-05
PCT/US2004/007213 WO2004081527A2 (en) 2003-03-10 2004-03-10 Systems for differential ion mobility analysis

Publications (1)

Publication Number Publication Date
EP1601948A2 true EP1601948A2 (de) 2005-12-07

Family

ID=35261943

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04719211A Withdrawn EP1601948A2 (de) 2003-03-10 2004-03-10 Systeme zur differential-ionenmobilitätsanalyse

Country Status (3)

Country Link
EP (1) EP1601948A2 (de)
CA (1) CA2518703A1 (de)
WO (1) WO2004081527A2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2759151C1 (ru) * 2020-11-18 2021-11-09 Федеральное государственное казенное военное образовательное учреждение высшего образования "Военный учебно-научный центр Военно-воздушных сил "Военно-воздушная академия имени профессора Н.Е. Жуковского и Ю.А. Гагарина" (г. Воронеж) Министерства обороны Российской Федерации Свч-устройство для определения электрофизических параметров и оценки дефектов в многослойных диэлектрических и магнитодиэлектрических покрытиях
US11484027B2 (en) 2020-10-29 2022-11-01 Industrial Polymers and Chemicals, Inc. Air filter with pathogen monitoring and inactivation

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0613882D0 (en) 2006-07-12 2006-08-23 Kidde Ip Holdings Ltd Smoke detector
DE102007033906A1 (de) * 2007-07-20 2009-01-29 Gesellschaft zur Förderung der Analytischen Wissenschaften e.V. Verfahren zur Analyse von Gasen, insbesondere zur Analyse der menschlichen Ausatemluft
US20090111189A1 (en) * 2007-10-26 2009-04-30 Alberta Research Council Inc. Organic and inorganic mercury detection
CN102313775B (zh) * 2010-07-06 2013-05-29 同方威视技术股份有限公司 离子迁移谱仪及其检测方法
DE102010045491B4 (de) * 2010-09-16 2012-10-11 Continental Automotive Gmbh Verfahren zum Nachweis von makromolekularen Silicium-organischen Verbindungen und Vorrichtung hierfür
US9173389B2 (en) * 2010-11-18 2015-11-03 Auburn University Systems and methods to deliver and maintain volatile compounds
DE102011017280A1 (de) * 2011-04-15 2012-10-18 Fagus-Grecon Greten Gmbh & Co Kg Verfahren zum Messen von emittierenden flüchtigen Stoffen aus Holzwerkstoffen und Vorrichtung zum Messen von emittierenden flüchtigen Stoffen aus Holzwerkstoffen
CN110133300B (zh) * 2012-03-18 2022-02-25 镜株式会社 疾病样品分析装置、分析系统及分析方法
ITUD20130021A1 (it) * 2013-02-20 2014-08-21 Alifax Holding S P A Procedimento per l'identificazione di classi batteriche tramite gas cromatografia/spettrometria di massa in campioni biologici
WO2015009613A2 (en) * 2013-07-16 2015-01-22 Cdx, Inc. Apparatus for detection and delivery of volatilized compounds and related methods
GB201314252D0 (en) * 2013-08-08 2013-09-25 Smiths Detection Watford Ltd Apparatus and method
GB2521753B (en) * 2013-11-21 2020-12-30 Hamilton Sundstrand Corp High temperature differential ion mobility spectroscopy
US9057699B2 (en) 2013-11-21 2015-06-16 Hamilton Sundstrand Corporation High temperature differential ion mobility spectroscopy
US10393749B2 (en) 2013-12-11 2019-08-27 Shiseido Company, Ltd. Marker for early diagnosis of kidney failure
EP2887065A1 (de) 2013-12-17 2015-06-24 Forest Laboratories Deutschland GmbH Verfahren zur Atemgasanalyse bei infektiösen Erkrankungen
CN104007214B (zh) * 2014-02-14 2015-12-02 西安科技大学 一种基于py-gc-ms检测香品中挥发性成分的方法
EP3198627B1 (de) * 2014-09-26 2025-10-29 Micromass UK Limited Genaue mobilitätschromatogramme
US12064239B2 (en) * 2017-03-23 2024-08-20 Technion Research & Development Foundation Limited Device and methods for detection and monitoring of tuberculosis
DE102017220514A1 (de) * 2017-11-16 2019-05-16 Unisensor Sensorsysteme Gmbh Verfahren und Vorrichtung zur Detektion von Fremdstoffen in einem flüssigen Medium
GB2568876A (en) * 2017-11-27 2019-06-05 Imperial Innovations Ltd Detection of biomarkers
CN110057757B (zh) * 2018-01-18 2022-04-26 深圳市理邦精密仪器股份有限公司 血红蛋白及其衍生物的识别、识别网络构建方法及装置
CN109738569B (zh) * 2019-02-28 2022-02-01 云南中烟工业有限责任公司 一种基于spme-gc-ms的高仿卷烟鉴别方法
CN110879265B (zh) * 2019-11-07 2023-03-31 云南中烟工业有限责任公司 一种卷烟爆珠中甲醛和乙醛向烟气受热迁移量模拟测定方法
CN110907556A (zh) * 2019-12-10 2020-03-24 湖北中烟工业有限责任公司 一种基于gc-ims对不同产地烟草香气的评价方法
JP7276751B2 (ja) * 2020-03-05 2023-05-18 新東工業株式会社 ガス測定器及びガス測定方法
US20240210382A1 (en) * 2020-03-19 2024-06-27 Respiration Scan Ltd Methods, database and system for use with viral infection
CN111551644A (zh) * 2020-04-03 2020-08-18 黄埔海关技术中心 基于离子迁移谱技术对进口香米原产地溯源的方法
CN112684061A (zh) * 2021-01-19 2021-04-20 泸州品创科技有限公司 用于茶香气提取过程的质量控制方法及系统
DE102021117816A1 (de) 2021-07-09 2023-01-12 B. Braun Melsungen Aktiengesellschaft Messvorrichtung mit zwei aufeinanderfolgenden Messungen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508204A (en) * 1995-01-12 1996-04-16 Norman Clinical Laboratories, Inc. Multiple sample sequential chemical analysis
US6540691B1 (en) * 1999-01-12 2003-04-01 Michael Phillips Breath test for the detection of various diseases
US7005632B2 (en) * 2002-04-12 2006-02-28 Sionex Corporation Method and apparatus for control of mobility-based ion species identification
US6806463B2 (en) * 1999-07-21 2004-10-19 The Charles Stark Draper Laboratory, Inc. Micromachined field asymmetric ion mobility filter and detection system
US6690004B2 (en) * 1999-07-21 2004-02-10 The Charles Stark Draper Laboratory, Inc. Method and apparatus for electrospray-augmented high field asymmetric ion mobility spectrometry
US6495823B1 (en) * 1999-07-21 2002-12-17 The Charles Stark Draper Laboratory, Inc. Micromachined field asymmetric ion mobility filter and detection system
US7057168B2 (en) * 1999-07-21 2006-06-06 Sionex Corporation Systems for differential ion mobility analysis
US6815668B2 (en) * 1999-07-21 2004-11-09 The Charles Stark Draper Laboratory, Inc. Method and apparatus for chromatography-high field asymmetric waveform ion mobility spectrometry
US6512224B1 (en) * 1999-07-21 2003-01-28 The Charles Stark Draper Laboratory, Inc. Longitudinal field driven field asymmetric ion mobility filter and detection system
US6680203B2 (en) * 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
EP1405065B1 (de) * 2001-06-30 2012-04-11 Dh Technologies Development Pte. Ltd. System zum sammeln von daten und zur identifizierung unbekannter substanzen in einem elektrischen feld

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004081527A3 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11484027B2 (en) 2020-10-29 2022-11-01 Industrial Polymers and Chemicals, Inc. Air filter with pathogen monitoring and inactivation
US11684066B1 (en) 2020-10-29 2023-06-27 Industrial Polymers and Chemicals, Inc. Air filter with pathogen monitoring and inactivation
US11766040B2 (en) 2020-10-29 2023-09-26 Industrial Polymers and Chemicals, Inc. Air filter with pathogen monitoring and inactivation
US11793194B2 (en) 2020-10-29 2023-10-24 Industrial Polymers and Chemicals, Inc. Air filter with pathogen monitoring and inactivation
RU2759151C1 (ru) * 2020-11-18 2021-11-09 Федеральное государственное казенное военное образовательное учреждение высшего образования "Военный учебно-научный центр Военно-воздушных сил "Военно-воздушная академия имени профессора Н.Е. Жуковского и Ю.А. Гагарина" (г. Воронеж) Министерства обороны Российской Федерации Свч-устройство для определения электрофизических параметров и оценки дефектов в многослойных диэлектрических и магнитодиэлектрических покрытиях

Also Published As

Publication number Publication date
WO2004081527A2 (en) 2004-09-23
WO2004081527A3 (en) 2007-04-19
CA2518703A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
US7057168B2 (en) Systems for differential ion mobility analysis
WO2004081527A2 (en) Systems for differential ion mobility analysis
Yue et al. Plasma‐based ambient mass spectrometry: Recent progress and applications
EP2212903B1 (de) Massenspektrometrie von chemischen ionisationsreaktionen oder protonentransferreaktionen mit einem quadrupol- oder laufzeit-massenspektrometer
US8334505B2 (en) Chemical ionization reaction or proton transfer reaction mass spectrometry
Rankin‐Turner et al. Applications of ambient ionization mass spectrometry in 2020: An annual review
US7388195B2 (en) Apparatus and systems for processing samples for analysis via ion mobility spectrometry
Kientz Chromatography and mass spectrometry of chemical warfare agents, toxins and related compounds: state of the art and future prospects
Andreu et al. Determination of currently used pesticides in biota
US9541525B2 (en) Substances detection system and method
Schmidt et al. Microfabricated differential mobility spectrometry with pyrolysis gas chromatography for chemical characterization of bacteria
WO2004090534A1 (en) Non-invasive breath analysis using field asymmetric ion mobility spectrometry
Dworzanski et al. Field‐portable, automated pyrolysis‐GC/IMS system for rapid biomarker detection in aerosols: A feasibility study
WO2007120373A2 (en) Differential mobility spectrometer analyzer and pre-filter apparatus, methods and systems
Kleeblatt et al. Detection of gaseous compounds by needle trap sampling and direct thermal-desorption photoionization mass spectrometry: concept and demonstrative application to breath gas analysis
Henderson et al. Advancements in ambient ionisation mass spectrometry in 2024: An annual review
Qu et al. A modified QuEChERS-DART-MS/MS technique for high-throughput detection of organophosphate nerve agent hydrolysis products in environmental samples
EP1963835A1 (de) Verfahren und vorrichtung zur probenanalyse auf ionenmobilitätsbasis
Hart et al. Design, development, and performance of a fieldable chemical and biological agent detector
US10119937B2 (en) Method for detecting organophosphorus compounds and illicit drugs
Ruiz-Jiménez et al. A complete methodology for the reliable collection, sample preparation, separation and determination of organic compounds in ultrafine 30 nm, 40 nm and 50 nm atmospheric aerosol particles
US20220386892A1 (en) Method of breath screening of viral infection
Thalavitiya Acharige et al. The use of microbial metabolites for the diagnosis of infectious diseases
Yang et al. Hyphenated differential mobility spectrometry for rapid separation and detection.
Lawrence et al. New applications for ion mobility spectrometry detection techniques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050902

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

RIC1 Information provided on ipc code assigned before grant

Ipc: H01J 49/00 20060101AFI20070424BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091001